background	background	NN	B-NP
chemokine	chemokine	NN	I-NP
are	are	VBP	0
small	small	JJ	0
,	,	,	0
positively	positively	RB	0
charged	charged	VBN	0
,	,	,	0
secreted	secreted	JJ	0
proteins	proteins	NNS	0
that	that	WDT	0
consist	consist	VBP	0
of	of	IN	0
an	an	DT	0
N-terminal	N-terminal	JJ	B-NP
region	region	NN	I-NP
of	of	IN	0
variable	variable	JJ	0
conformation	conformation	NN	B-NP
,	,	,	0
three	three	CD	0
antiparallel	antiparallel	CD	B-NP
beta-pleated	beta-pleated	JJ	0
sheets	sheets	NNS	0
connected	connected	VBN	0
by	by	IN	0
loops	loops	NNS	0
,	,	,	0
and	and	CC	0
a	a	DT	0
C-terminal	C-terminal	JJ	B-NP
alpha	alpha	NN	I-NP
helix	helix	NN	I-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
proteins	proteins	NNS	0
are	are	VBP	0
multifunctional	multifunctional	VBN	0
,	,	,	0
with	with	IN	0
different	different	JJ	0
regions	regions	NNS	0
of	of	IN	0
the	the	DT	0
molecules	molecules	NN	0
,	,	,	0
in	in	IN	0
particular	particular	JJ	0
the	the	DT	0
N-	N-	JJ	0
and	and	CC	0
c-terminus	c-terminus	NN	B-NP
,	,	,	0
performing	performing	VBG	0
specific	specific	JJ	0
functions	functions	NNS	0
[	[	-LRB-	0
e.g.	e.g.	NNP	0
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
3	3	CD	0
4	4	CD	0
]	]	CD	0
]	]	-RRB-	0
.	.	.	0
chemokine	chemokine	NN	B-NP
are	are	VBP	0
best	best	RB	0
known	known	VBN	0
for	for	IN	0
their	their	PRP$	0
functions	functions	NNS	0
in	in	IN	0
attracting	attracting	VBG	0
and	and	CC	0
activating	activating	JJ	0
leukocyte	leukocyte	NN	B-NP
.	.	.	0
Shortly	Shortly	RB	0
after	after	IN	0
injury	injury	NN	B-NP
,	,	,	0
these	these	DT	0
small	small	JJ	0
cytokine	cytokine	NN	B-NP
are	are	VBP	0
primarily	primarily	RB	0
produced	produced	VBN	0
by	by	IN	0
fibroblast	fibroblast	NN	B-NP
,	,	,	0
chemoattract	chemoattract	JJ	B-NP
leukocyte	leukocyte	NN	I-NP
and	and	CC	0
activate	activate	VBP	0
their	their	PRP$	0
integrin	integrin	NN	B-NP
causing	causing	VBG	0
them	them	PRP	0
to	to	TO	0
adhere	adhere	VB	0
strongly	strongly	RB	0
to	to	TO	0
the	the	DT	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
as	as	IN	0
a	a	DT	0
prelude	prelude	NN	B-NP
to	to	TO	0
their	their	PRP$	0
migration	migration	NN	0
through	through	IN	0
the	the	DT	0
blood	blood	NN	0
vessel	vessel	NN	0
wall	wall	NN	0
to	to	TO	0
the	the	DT	0
underlying	underlying	JJ	0
tissue	tissue	NN	0
and	and	CC	0
towards	towards	IN	0
the	the	DT	0
source	source	NN	0
of	of	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
[	[	-LRB-	0
5	5	LS	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
these	these	DT	0
functions	functions	NNS	0
during	during	IN	0
the	the	DT	0
early	early	JJ	0
stages	stages	NNS	0
of	of	IN	0
wound	wound	JJ	B-NP
healing	healing	NN	I-NP
,	,	,	0
these	these	DT	0
small	small	JJ	0
cytokine	cytokine	NN	B-NP
are	are	VBP	0
also	also	RB	0
known	known	VBN	0
to	to	TO	0
be	be	VB	0
involved	involved	VBN	0
in	in	IN	0
re-epithelialization	re-epithelialization	NNP	B-NP
,	,	,	0
angiogenesi	angiogenesi	NN	B-NP
and	and	CC	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
development	development	NN	I-NP
[	[	-LRB-	0
3	3	CD	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
,	,	,	0
processes	processes	NNS	0
that	that	WDT	0
are	are	VBP	0
critical	critical	JJ	0
for	for	IN	0
proper	proper	JJ	0
healing	healing	NN	0
.	.	.	0
The	The	DT	0
first	first	JJ	0
evidence	evidence	NN	0
that	that	IN	0
chemokine	chemokine	NN	B-NP
are	are	VBP	0
associated	associated	VBN	0
with	with	IN	0
wound	wound	JJ	B-NP
healing	healing	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
was	was	VBD	0
reported	reported	VBN	0
in	in	IN	0
1990	1990	CD	0
using	using	VBG	0
the	the	DT	0
chemokine	chemokine	JJ	B-NP
cCAF	cCAF	NN	I-NP
(	(	-LRB-	0
chicken	chicken	NN	B-NP
Chemotactic	Chemotactic	NNP	I-NP
and	and	CC	0
Angiogenic	Angiogenic	NNP	B-NP
Factor	Factor	NNP	I-NP
;	;	:	0
the	the	DT	0
product	product	NN	0
of	of	IN	0
the	the	DT	0
9E3	9E3	JJ	B-NP
gene	gene	NN	I-NP
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
CXC	CXC	NNP	0
chemokine	chemokine	NN	B-NP
that	that	WDT	0
is	is	VBZ	0
now	now	RB	0
known	known	VBN	0
to	to	TO	0
be	be	VB	0
the	the	DT	0
ortologue	ortologue	NN	B-NP
for	for	IN	0
human	human	JJ	0
IL-8	IL-8	NNP	B-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
cCAF	cCAF	SYM	B-NP
is	is	VBZ	0
expressed	expressed	VBN	0
to	to	TO	0
high	high	JJ	0
levels	levels	NNS	0
very	very	RB	0
shortly	shortly	RB	0
after	after	IN	0
wounding	wounding	NN	0
and	and	CC	0
during	during	IN	0
the	the	DT	0
first	first	JJ	0
24-48	24-48	CD	0
hours	hours	NNS	0
after	after	IN	0
injury	injury	NN	B-NP
,	,	,	0
and	and	CC	0
remains	remains	VBZ	0
elevated	elevated	VBN	0
for	for	IN	0
at	at	IN	0
least	least	JJS	0
16	16	CD	0
days	days	NNS	0
after	after	IN	0
wounding	wounding	NNS	0
[	[	-LRB-	0
6	6	CD	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
primarily	primarily	RB	0
expressed	expressed	VBN	0
by	by	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
fibroblast	fibroblast	NN	I-NP
,	,	,	0
especially	especially	RB	0
where	where	WRB	0
interstitial	interstitial	JJ	B-NP
collagen	collagen	NN	I-NP
(	(	-LRB-	0
Coll	Coll	NNP	0
)	)	-RRB-	0
is	is	VBZ	0
abundant	abundant	JJ	0
,	,	,	0
but	but	CC	0
the	the	DT	0
levels	levels	NNS	0
are	are	VBP	0
also	also	RB	0
high	high	JJ	0
in	in	IN	0
the	the	DT	0
microvessel	microvessel	NN	B-NP
endothelial	endothelial	JJ	I-NP
cell	cell	NN	I-NP
,	,	,	0
in	in	IN	0
the	the	DT	0
healing	healing	NN	0
epidermis	epidermis	NNS	0
and	and	CC	0
in	in	IN	0
the	the	DT	0
connective	connective	JJ	B-NP
tissue	tissue	NN	I-NP
beneath	beneath	IN	0
the	the	DT	0
skin	skin	NN	0
[	[	-LRB-	0
6	6	CD	0
11	11	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
chicken	chicken	NN	B-NP
chorioallantoic	chorioallantoic	NN	I-NP
membrane	membrane	NN	I-NP
(	(	-LRB-	0
CAM	CAM	NNP	B-NP
)	)	-RRB-	0
assay	assay	NN	B-NP
,	,	,	0
low	low	JJ	0
ccaf	ccaf	NN	B-NP
result	result	NN	I-NP
concentration	concentration	NN	I-NP
in	in	IN	0
monocyte/macrophage	monocyte/macrophage	NN	B-NP
chemotaxi	chemotaxi	NN	I-NP
and	and	CC	0
lymphocyte	lymphocyte	NN	B-NP
and	and	CC	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
a	a	DT	0
granulation-like	granulation-like	JJ	B-NP
tissue	tissue	NN	I-NP
beneath	beneath	IN	0
the	the	DT	0
chemokine-containing	chemokine-containing	JJ	B-NP
pellet	pellet	NN	I-NP
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
After	After	IN	0
four	four	CD	0
days	days	NNS	0
of	of	IN	0
exposure	exposure	NN	0
to	to	TO	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
,	,	,	0
the	the	DT	0
ectoderm	ectoderm	NN	B-NP
of	of	IN	0
the	the	DT	0
CAMs	CAMs	NN	0
becomes	becomes	VBZ	0
thickened	thickened	VBN	0
and	and	CC	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
fibrillar	fibrillar	JJ	B-NP
collagen	collagen	NN	I-NP
in	in	IN	0
the	the	DT	0
tissue	tissue	NN	0
is	is	VBZ	0
markedly	markedly	RB	0
increased	increased	VBN	0
,	,	,	0
strongly	strongly	RB	0
suggesting	suggesting	VBG	0
that	that	IN	0
cCAF	cCAF	NNP	B-NP
is	is	VBZ	0
able	able	JJ	0
to	to	TO	0
initiate	initiate	VB	0
some	some	DT	0
of	of	IN	0
the	the	DT	0
primary	primary	JJ	B-NP
event	event	NN	I-NP
that	that	WDT	0
lead	lead	VBP	0
to	to	TO	0
granulation	granulation	VB	0
tissue	tissue	NN	0
formation	formation	NN	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
fibroblast	fibroblast	NN	B-NP
are	are	VBP	0
important	important	JJ	0
cells	cells	NNS	0
in	in	IN	0
the	the	DT	0
healing	healing	NN	B-NP
process	process	NN	I-NP
.	.	.	0
Upon	Upon	IN	0
injury	injury	NN	B-NP
,	,	,	0
they	they	PRP	0
are	are	VBP	0
activated	activated	VBN	0
by	by	IN	0
the	the	DT	0
cytokine	cytokine	NN	B-NP
and	and	CC	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
released	released	VBN	0
during	during	IN	0
the	the	DT	0
coagulation	coagulation	JJ	B-NP
process	process	NN	I-NP
to	to	TO	0
produce	produce	VB	0
chemokine	chemokine	NN	B-NP
and	and	CC	0
additional	additional	JJ	0
cytokine	cytokine	NN	B-NP
and	and	CC	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
that	that	WDT	0
are	are	VBP	0
important	important	JJ	0
in	in	IN	0
setting	setting	VBG	0
up	up	RP	0
the	the	DT	0
cascade	cascade	NN	0
of	of	IN	0
events	events	NNS	0
that	that	WDT	0
lead	lead	VBP	0
to	to	TO	0
granulation	granulation	VB	0
tissue	tissue	NN	0
formation	formation	NN	0
.	.	.	0
activated	activated	VBN	B-NP
fibroblast	fibroblast	NN	I-NP
proliferate	proliferate	NN	0
and	and	CC	0
migrate	migrate	VB	0
across	across	IN	0
the	the	DT	0
provisional	provisional	JJ	0
matrix	matrix	NN	B-NP
formed	formed	VBN	0
by	by	IN	0
the	the	DT	0
fibrin-plasma	fibrin-plasma	JJ	B-NP
fibronectin	fibronectin	NN	I-NP
(	(	-LRB-	0
FN	FN	NNP	B-NP
)	)	-RRB-	0
clot	clot	NN	0
.	.	.	0
As	As	IN	0
the	the	DT	0
clot	clot	NN	0
is	is	VBZ	0
digested	digested	VBN	0
by	by	IN	0
plasmin	plasmin	NN	B-NP
,	,	,	0
fibroblasts	fibroblasts	RB	0
replace	replace	VB	0
it	it	PRP	0
with	with	IN	0
cellular	cellular	JJ	B-NP
FN	FN	NNP	I-NP
,	,	,	0
tenascin	tenascin	NN	B-NP
(	(	-LRB-	0
TN	TN	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
Coll	Coll	NNP	0
III	III	NNP	0
[	[	-LRB-	0
12	12	CD	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	JJ	I-NP
protein	protein	NN	I-NP
are	are	VBP	0
critical	critical	JJ	0
for	for	IN	0
migration	migration	NN	0
of	of	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
keratinocyte	keratinocyte	NN	B-NP
and	and	CC	0
additional	additional	JJ	0
fibroblast	fibroblast	NN	B-NP
into	into	IN	0
the	the	DT	0
wound	wound	NN	0
and	and	CC	0
are	are	VBP	0
important	important	JJ	0
for	for	IN	0
proper	proper	JJ	0
generation	generation	NN	0
of	of	IN	0
healthy	healthy	JJ	0
healing	healing	NN	0
tissue	tissue	NN	0
.	.	.	0
Some	Some	DT	0
of	of	IN	0
the	the	DT	0
fibroblasts	fibroblasts	JJ	0
differentiate	differentiate	NN	0
into	into	IN	0
myofibroblast	myofibroblast	NN	B-NP
,	,	,	0
which	which	WDT	0
contract	contract	NN	0
to	to	TO	0
close	close	VB	0
the	the	DT	0
wound	wound	NN	0
[	[	-LRB-	0
4	4	CD	0
14	14	CD	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
myofibroblast	myofibroblast	NN	B-NP
are	are	VBP	0
fibrogenic	fibrogenic	VBN	0
,	,	,	0
showing	showing	VBG	0
elevated	elevated	JJ	0
expression	expression	NN	0
of	of	IN	0
interstitial	interstitial	JJ	B-NP
collagen	collagen	NN	I-NP
,	,	,	0
laminin	laminin	NN	B-NP
,	,	,	0
fibronectin	fibronectin	NN	B-NP
and	and	CC	0
tenascin	tenascin	NN	B-NP
,	,	,	0
and	and	CC	0
inhibitors	inhibitors	NN	0
of	of	IN	0
matrix	matrix	JJ	B-NP
metalloproteinases	metalloproteinases	JJ	0
such	such	JJ	0
as	as	IN	0
TIMP-1	TIMP-1	NNP	B-NP
[	[	-LRB-	0
15	15	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
cCAF	cCAF	NNP	B-NP
is	is	VBZ	0
expressed	expressed	VBN	0
highly	highly	RB	0
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
of	of	IN	0
wounds	wounds	NNS	0
in	in	IN	0
areas	areas	NNS	0
where	where	WRB	0
extracellular	extracellular	NN	B-NP
matrix	matrix	NN	I-NP
is	is	VBZ	0
abundant	abundant	JJ	0
[	[	-LRB-	0
3	3	CD	0
6	6	CD	0
11	11	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
it	it	PRP	0
stimulates	stimulates	VBP	0
fibroblasts	fibroblasts	VBN	0
to	to	TO	0
differentiate	differentiate	VB	0
into	into	IN	0
myofibroblast	myofibroblast	NN	B-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
investigated	investigated	VBD	0
whether	whether	IN	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
stimulates	stimulates	VBD	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
the	the	DT	0
four	four	CD	0
major	major	JJ	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
mentioned	mentioned	VBN	0
above	above	IN	0
,	,	,	0
interstitial	interstitial	VBG	0
coll	coll	NNP	B-NP
I	I	NNP	0
and	and	CC	0
III	III	NNP	0
,	,	,	0
tenascin	tenascin	NN	B-NP
and	and	CC	0
cellular	cellular	JJ	B-NP
FN	FN	NNP	I-NP
.	.	.	0
Here	Here	RB	0
we	we	PRP	0
show	show	VBP	0
that	that	IN	0
cCAF	cCAF	JJ	0
stimulates	stimulates	JJ	0
cultures	cultures	NNS	0
of	of	IN	0
fibroblasts	fibroblasts	VBG	0
to	to	TO	0
produce	produce	VB	0
tenascin	tenascin	NN	B-NP
,	,	,	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
and	and	CC	0
Coll	Coll	NNP	0
I	I	NNP	0
,	,	,	0
albeit	albeit	VBG	0
with	with	IN	0
different	different	JJ	0
dynamics	dynamics	NNS	0
and	and	CC	0
that	that	IN	0
these	these	DT	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
are	are	VBP	0
also	also	RB	0
increased	increased	VBN	0
in	in	IN	0
wounded	wounded	JJ	0
tissues	tissues	NNS	0
treated	treated	VBN	0
with	with	IN	0
cCAF	cCAF	JJ	0
.	.	.	0
Results	Results	NNP	0
Effects	Effects	NNPS	0
of	of	IN	0
cCAF	cCAF	JJ	0
and	and	CC	0
its	its	PRP$	0
peptide	peptide	NN	B-NP
on	on	IN	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
tenascin	tenascin	NN	B-NP
In	In	IN	0
adults	adults	NNS	0
,	,	,	0
tenascin	tenascin	NN	B-NP
,	,	,	0
specifically	specifically	RB	0
TN	TN	NNP	B-NP
C	C	NNP	I-NP
,	,	,	0
is	is	VBZ	0
present	present	RB	0
almost	almost	RB	0
exclusively	exclusively	RB	0
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
of	of	IN	0
healing	healing	JJ	0
wounds	wounds	NNS	0
[	[	-LRB-	0
12	12	CD	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
providing	providing	VBG	0
a	a	DT	0
rapid	rapid	JJ	B-NP
migration	migration	NN	I-NP
matrix	matrix	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
during	during	IN	0
wound	wound	JJ	B-NP
repair	repair	NN	I-NP
,	,	,	0
tenascin	tenascin	NN	B-NP
supports	supports	VBZ	0
fibroblast	fibroblast	NN	B-NP
differentiation	differentiation	VBN	I-NP
into	into	IN	0
myofibroblast	myofibroblast	NN	B-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
,	,	,	0
which	which	WDT	0
then	then	RB	0
produce	produce	VB	0
more	more	JJR	0
tenascin	tenascin	NN	B-NP
than	than	IN	0
do	do	VBP	0
normal	normal	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
cCAF	cCAF	JJ	0
stimulates	stimulates	JJ	0
fibroblast	fibroblast	NN	B-NP
to	to	TO	0
differentiate	differentiate	VB	0
into	into	IN	0
myofibroblast	myofibroblast	NN	B-NP
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
also	also	RB	0
affects	affects	VBZ	0
TN	TN	NNP	B-NP
production	production	NN	I-NP
.	.	.	0
Immunolabeling	Immunolabeling	NNP	B-NP
of	of	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
daily	daily	RB	0
for	for	IN	0
four	four	CD	0
days	days	NNS	0
with	with	IN	0
750	750	CD	0
chemokine	chemokine	NN	B-NP
ng/ml	ng/ml	NN	I-NP
showed	showed	VBD	0
that	that	DT	0
cCAF	cCAF	JJ	0
stimulates	stimulates	NNS	0
the	the	DT	0
cells	cells	NNS	0
to	to	TO	0
produce	produce	VB	0
more	more	JJR	0
tenascin	tenascin	NN	B-NP
than	than	IN	0
the	the	DT	0
control	control	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
&	&	CC	0
1B	1B	CD	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
previously	previously	RB	0
determined	determined	VBN	0
,	,	,	0
using	using	VBG	0
dose-dependent	dose-dependent	JJ	B-NP
study	study	NN	I-NP
,	,	,	0
that	that	IN	0
this	this	DT	0
concentration	concentration	NN	B-NP
is	is	VBZ	0
optimal	optimal	VBN	0
for	for	IN	0
functions	functions	NNS	0
of	of	IN	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
on	on	IN	0
these	these	DT	0
embryonic	embryonic	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
and	and	CC	0
in	in	IN	0
processes	processes	NNS	0
of	of	IN	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
formation	formation	NN	I-NP
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
Although	Although	IN	0
chemokine	chemokine	JJ	B-NP
concentration	concentration	NN	I-NP
of	of	IN	0
10	10	CD	0
-2-10	-2-10	CD	0
ng	ng	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
can	can	MD	0
chemoattract	chemoattract	VB	0
and	and	CC	0
activate	activate	JJ	0
leukocyte	leukocyte	NN	B-NP
,	,	,	0
chemokines	chemokines	VBZ	0
acting	acting	VBG	0
on	on	IN	0
other	other	JJ	0
cell	cell	NN	0
types	types	NNS	0
such	such	JJ	0
as	as	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
smooth	smooth	JJ	0
muscle	muscle	NN	B-NP
cell	cell	NN	I-NP
and	and	CC	0
fibroblast	fibroblast	NN	B-NP
require	require	VBP	0
concentration	concentration	NN	B-NP
in	in	IN	0
the	the	DT	0
range	range	NN	0
of	of	IN	0
10	10	CD	0
2ng	2ng	CD	B-NP
/	/	CD	0
ml	ml	NNS	0
and	and	CC	0
higher	higher	JJR	0
[	[	-LRB-	0
4	4	CD	0
26	26	CD	0
27	27	CD	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
is	is	VBZ	0
within	within	IN	0
physiological	physiological	JJ	B-NP
range	range	NN	I-NP
;	;	:	0
for	for	IN	0
example	example	NN	0
wound	wound	VBD	0
fluid	fluid	VBN	B-NP
from	from	IN	0
burn	burn	JJ	B-NP
patient	patient	JJ	I-NP
contain	contain	VBP	0
MGSA	MGSA	NNP	B-NP
(	(	-LRB-	0
a	a	DT	0
chemokine	chemokine	NN	B-NP
that	that	WDT	0
is	is	VBZ	0
highly	highly	RB	0
homologous	homologous	VBN	0
to	to	TO	0
cCAF	cCAF	NNP	B-NP
)	)	-RRB-	0
concentration	concentration	NN	B-NP
of	of	IN	0
10	10	CD	0
2-10	2-10	CD	0
3ng	3ng	CD	B-NP
/	/	CD	0
ml	ml	NNS	0
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
both	both	PDT	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
and	and	CC	0
ccaf	ccaf	NN	B-NP
c-terminal	c-terminal	NN	I-NP
peptide	peptide	NN	I-NP
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
functional	functional	VBN	0
in	in	IN	0
culture	culture	NN	0
and	and	CC	0
in	in	IN	0
vivo	vivo	NN	B-NP
(	(	-LRB-	0
1-4	1-4	NNP	0
,	,	,	0
30	30	CD	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
also	also	RB	0
tested	tested	VBN	0
these	these	DT	0
two	two	CD	0
peptide	peptide	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
N-terminal	N-terminal	JJ	0
15aa	15aa	CD	0
peptide	peptide	NNS	0
produced	produced	VBD	0
an	an	DT	0
effect	effect	NN	0
at	at	IN	0
least	least	JJS	0
as	as	IN	0
strong	strong	JJ	0
as	as	IN	0
the	the	DT	0
whole	whole	JJ	0
molecule	molecule	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1C	1C	NNP	0
)	)	-RRB-	0
whereas	whereas	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
the	the	DT	0
C-terminal	C-terminal	JJ	B-NP
peptida	peptida	NN	I-NP
(	(	-LRB-	0
28aa	28aa	NNP	0
)	)	-RRB-	0
was	was	VBD	0
closer	closer	JJR	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
the	the	DT	0
control	control	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1D	1D	NNP	0
)	)	-RRB-	0
.	.	.	0
Western	Western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
of	of	IN	0
extracts	extracts	NN	0
from	from	IN	0
treated	treated	JJ	0
fibroblast	fibroblast	NN	B-NP
confirmed	confirmed	VBD	0
that	that	DT	0
tenascin	tenascin	NN	B-NP
ccaf	ccaf	NN	I-NP
increases	increases	NNS	I-NP
production	production	NN	I-NP
in	in	IN	0
culture	culture	NN	0
,	,	,	0
that	that	IN	0
this	this	DT	0
effect	effect	NN	0
also	also	RB	0
can	can	MD	0
be	be	VB	0
accomplished	accomplished	VBN	0
effectively	effectively	RB	0
by	by	IN	0
the	the	DT	0
N-peptide	N-peptide	JJ	B-NP
,	,	,	0
but	but	CC	0
that	that	IN	0
the	the	DT	0
C-peptide	C-peptide	NN	B-NP
produced	produced	VBD	0
an	an	DT	0
elevated	elevated	NN	0
,	,	,	0
but	but	CC	0
substantially	substantially	RB	0
smaller	smaller	JJR	0
,	,	,	0
response	response	NN	0
than	than	IN	0
either	either	RB	0
the	the	DT	0
N-peptide	N-peptide	JJ	B-NP
or	or	CC	0
the	the	DT	0
whole	whole	JJ	0
cCAF	cCAF	JJ	B-NP
molecule	molecule	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1E	1E	NNP	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
cCAF	cCAF	JJ	0
stimulates	stimulates	JJ	0
TN	TN	NNP	B-NP
expression	expression	NN	I-NP
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
mRNA	mRNA	JJ	0
for	for	IN	0
this	this	DT	0
ECM	ECM	NNP	B-NP
molecule	molecule	NN	I-NP
.	.	.	0
RT-PCR	RT-PCR	JJ	B-NP
analysis	analysis	NN	I-NP
showed	showed	VBD	0
significant	significant	JJ	0
increased	increased	JJ	0
levels	levels	NNS	0
of	of	IN	0
mRNA	mRNA	JJ	0
for	for	IN	0
tenascin	tenascin	NN	B-NP
after	after	IN	0
treatment	treatment	NN	0
with	with	IN	0
either	either	DT	0
cCAF	cCAF	JJ	0
or	or	CC	0
its	its	PRP$	0
N-peptide	N-peptide	JJ	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1F	1F	NNP	0
)	)	-RRB-	0
but	but	CC	0
the	the	DT	0
increase	increase	NN	0
stimulated	stimulated	VBN	0
by	by	IN	0
the	the	DT	0
C-terminus	C-terminus	NN	B-NP
is	is	VBZ	0
much	much	RB	0
smaller	smaller	JJR	0
correlating	correlating	NN	0
with	with	IN	0
the	the	DT	0
small	small	JJ	0
increase	increase	NN	0
in	in	IN	0
protein	protein	NN	B-NP
level	level	JJ	I-NP
.	.	.	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
this	this	DT	0
effect	effect	NN	0
is	is	VBZ	0
also	also	RB	0
observed	observed	VBN	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
excision	excision	JJ	B-NP
wound	wound	NN	I-NP
were	were	VBD	0
made	made	VBN	0
on	on	IN	0
the	the	DT	0
underside	underside	NN	0
of	of	IN	0
wings	wings	NNS	0
of	of	IN	0
2	2	CD	0
week-old	week-old	JJ	B-NP
chick	chick	NN	I-NP
.	.	.	0
To	To	TO	0
avoid	avoid	VB	0
variations	variations	NNS	0
in	in	IN	0
genetic	genetic	JJ	B-NP
background	background	NN	I-NP
,	,	,	0
for	for	IN	0
each	each	DT	0
bird	bird	NN	0
one	one	CD	0
wing	wing	NN	0
was	was	VBD	0
treated	treated	VBN	0
with	with	IN	0
vehicle	vehicle	NN	B-NP
and	and	CC	0
the	the	DT	0
other	other	JJ	0
with	with	IN	0
cCAF	cCAF	NNP	B-NP
,	,	,	0
and	and	CC	0
treatments	treatments	NNS	0
were	were	VBD	0
applied	applied	VBN	0
every	every	DT	0
other	other	JJ	0
day	day	NN	0
for	for	IN	0
5	5	CD	0
days	days	NNS	0
.	.	.	0
In	In	IN	0
normal	normal	JJ	B-NP
wound	wound	NN	I-NP
healing	healing	NN	I-NP
,	,	,	0
tenascin	tenascin	NN	B-NP
appeared	appeared	VBD	0
at	at	IN	0
days	days	NNS	0
2-3	2-3	CD	0
and	and	CC	0
disappeared	disappeared	VBD	0
during	during	IN	0
remodeling	remodeling	NN	0
which	which	WDT	0
begins	begins	VBZ	0
around	around	IN	0
day	day	NN	0
10	10	CD	0
after	after	IN	0
wounding	wounding	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
tissues	tissues	NNS	0
were	were	VBD	0
collected	collected	VBN	0
at	at	IN	0
days	days	NNS	0
3	3	CD	0
and	and	CC	0
7	7	CD	0
after	after	IN	0
wounding	wounding	NN	0
and	and	CC	0
analyzed	analyzed	VBD	0
for	for	IN	0
tenascin	tenascin	NN	B-NP
by	by	IN	0
immunostaining	immunostaining	NN	B-NP
and	and	CC	0
western	western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
&	&	CC	0
2B	2B	CD	0
)	)	-RRB-	0
.	.	.	0
protein	protein	NN	B-NP
immunoblot	immunoblot	NN	I-NP
analysis	analysis	NN	I-NP
extracted	extracted	VBN	0
from	from	IN	0
control	control	NN	B-NP
wound	wound	NN	I-NP
confirmed	confirmed	VBD	0
that	that	IN	0
TN	TN	NNP	B-NP
deposition	deposition	VBD	I-NP
begun	begun	VBN	0
by	by	IN	0
3	3	CD	0
days	days	NNS	0
and	and	CC	0
that	that	IN	0
it	it	PRP	0
increased	increased	VBD	0
dramatically	dramatically	RB	0
by	by	IN	0
7	7	CD	0
days	days	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2C	2C	NNP	0
,	,	,	0
Control	Control	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
by	by	IN	0
3	3	CD	0
days	days	NNS	0
,	,	,	0
ccaf-treated	ccaf-treated	NN	B-NP
wound	wound	NN	I-NP
already	already	RB	0
contained	contained	VBN	0
as	as	IN	0
much	much	JJ	0
tenascin	tenascin	NN	B-NP
as	as	IN	0
the	the	DT	0
control	control	NN	0
at	at	IN	0
7	7	CD	0
days	days	NNS	0
and	and	CC	0
that	that	IN	0
by	by	IN	0
7	7	CD	0
days	days	NNS	0
,	,	,	0
the	the	DT	0
tenascin	tenascin	NN	B-NP
is	is	VBZ	0
dramatically	dramatically	RB	0
reduced	reduced	VBN	0
by	by	IN	0
the	the	DT	0
ongoing	ongoing	JJ	0
processes	processes	NNS	0
of	of	IN	0
repair	repair	NN	0
(	(	-LRB-	0
Fig	Fig	NNP	0
2C	2C	NNP	0
,	,	,	0
cCAF	cCAF	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
addition	addition	NN	I-NP
to	to	TO	0
wounds	wounds	VB	0
shifts	shifts	NNS	0
the	the	DT	0
peak	peak	NN	0
of	of	IN	0
tenascin	tenascin	NN	B-NP
in	in	IN	0
the	the	DT	0
wound	wound	JJ	B-NP
tissue	tissue	NN	I-NP
to	to	TO	0
earlier	earlier	JJR	0
stages	stages	NNS	0
of	of	IN	0
wound	wound	JJ	B-NP
healing	healing	NN	I-NP
than	than	IN	0
in	in	IN	0
control	control	NN	B-NP
wound	wound	NN	I-NP
.	.	.	0
Effects	Effects	NNS	0
of	of	IN	0
cCAF	cCAF	JJ	0
and	and	CC	0
its	its	PRP$	0
peptide	peptide	NN	B-NP
on	on	IN	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
FN	FN	NNP	B-NP
Cellular	Cellular	NNP	I-NP
FN	FN	NNP	I-NP
is	is	VBZ	0
abundantly	abundantly	RB	0
present	present	VB	0
in	in	IN	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
,	,	,	0
is	is	VBZ	0
produced	produced	VBN	0
primarily	primarily	RB	0
by	by	IN	0
the	the	DT	0
wound	wound	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
and	and	CC	0
myofibroblast	myofibroblast	NN	B-NP
.	.	.	0
fibroblast	fibroblast	NN	B-NP
culture	culture	NN	I-NP
treated	treated	VBN	0
as	as	IN	0
for	for	IN	0
tenascin	tenascin	NN	B-NP
,	,	,	0
produced	produced	VBD	0
much	much	RB	0
more	more	JJR	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
as	as	RB	0
shown	shown	VBN	0
by	by	IN	0
immunolabeling	immunolabeling	NN	B-NP
(	(	-LRB-	0
Figs.	Figs.	NNP	0
3A	3A	NNP	0
&	&	CC	0
3B	3B	CD	0
)	)	-RRB-	0
and	and	CC	0
immunoblot	immunoblot	JJ	B-NP
analysis	analysis	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3E	3E	NNP	0
)	)	-RRB-	0
.	.	.	0
Unlike	Unlike	IN	0
tenascin	tenascin	NN	B-NP
,	,	,	0
this	this	DT	0
effect	effect	NN	0
can	can	MD	0
only	only	RB	0
be	be	VB	0
accomplished	accomplished	VBN	0
by	by	IN	0
the	the	DT	0
whole	whole	JJ	0
cCAF	cCAF	JJ	B-NP
molecule	molecule	NN	I-NP
;	;	:	0
immunolabeling	immunolabeling	NN	B-NP
and	and	CC	0
immunoblot	immunoblot	JJ	B-NP
analysis	analysis	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
the	the	DT	0
N-peptide	N-peptide	JJ	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3C	3C	NNP	0
&	&	CC	0
3E	3E	CD	0
)	)	-RRB-	0
or	or	CC	0
C-peptide	C-peptide	NNP	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3D	3D	NNP	0
&	&	CC	0
3E	3E	CD	0
)	)	-RRB-	0
revealed	revealed	VBD	0
similar	similar	JJ	0
FN	FN	NN	0
levels	levels	NNS	0
to	to	TO	0
control	control	VB	0
.	.	.	0
Unlike	Unlike	IN	0
TN	TN	NNP	0
,	,	,	0
cCAF	cCAF	NNP	0
did	did	VBD	0
not	not	RB	0
affect	affect	VB	0
FN	FN	JJ	0
mRNA	mRNA	JJ	0
levels	levels	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3F	3F	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
immunostaining	immunostaining	VBG	0
for	for	IN	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
3	3	CD	0
days	days	NNS	0
after	after	IN	0
making	making	VBG	B-NP
excision	excision	NN	I-NP
wound	wound	NN	I-NP
,	,	,	0
showed	showed	VBD	0
that	that	IN	0
levels	levels	NNS	0
of	of	IN	0
this	this	DT	0
protein	protein	NN	B-NP
are	are	VBP	0
high	high	JJ	0
in	in	IN	0
the	the	DT	0
healing	healing	NN	0
tissues	tissues	NNS	0
and	and	CC	0
that	that	DT	0
treatment	treatment	NN	0
with	with	IN	0
increased	increased	VBD	B-NP
fn	fn	NN	I-NP
accumulation	accumulation	NN	I-NP
ccaf	ccaf	NN	I-NP
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4A	4A	NNP	0
&	&	CC	0
4B	4B	CD	0
)	)	-RRB-	0
.	.	.	0
fibronectin	fibronectin	NN	B-NP
immunoblot	immunoblot	NN	I-NP
analysis	analysis	NN	I-NP
extracted	extracted	VBD	0
from	from	IN	0
excision	excision	JJ	B-NP
wound	wound	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
by	by	IN	0
3	3	CD	0
days	days	NNS	0
after	after	IN	0
injury	injury	VBG	B-NP
the	the	DT	0
ccaf-treated	ccaf-treated	NN	B-NP
wound	wound	NN	I-NP
contained	contained	VBD	0
more	more	JJR	0
fibronectin	fibronectin	NN	B-NP
than	than	IN	0
the	the	DT	0
control	control	NN	B-NP
wound	wound	NN	I-NP
but	but	CC	0
that	that	IN	0
the	the	DT	0
levels	levels	NNS	0
by	by	IN	0
7	7	CD	0
days	days	NNS	0
are	are	VBP	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
the	the	DT	0
control	control	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4C	4C	NNP	0
)	)	-RRB-	0
.	.	.	0
Taken	Taken	VBN	0
together	together	RP	0
the	the	DT	0
results	results	NNS	0
in	in	IN	0
culture	culture	NN	0
and	and	CC	0
in	in	IN	0
vivo	vivo	NN	B-NP
suggest	suggest	VBP	0
that	that	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
does	does	VBZ	0
not	not	RB	0
stimulate	stimulate	VB	0
FN	FN	JJ	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
but	but	CC	0
rather	rather	RB	0
may	may	MD	0
directly	directly	RB	0
or	or	CC	0
indirectly	indirectly	RB	0
affect	affect	VB	0
stability	stability	NN	0
of	of	IN	0
this	this	DT	0
protein	protein	NN	B-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
leads	leads	VBZ	0
to	to	TO	0
stability	stability	NN	0
of	of	IN	0
the	the	DT	0
protein	protein	NN	B-NP
by	by	IN	0
stimulating	stimulating	VBG	B-NP
decrease	decrease	NN	I-NP
in	in	IN	0
matrix	matrix	JJ	B-NP
degrading	degrading	JJ	0
enzymes	enzymes	NN	0
.	.	.	0
In	In	IN	0
chickens	chickens	NNS	0
,	,	,	0
plasmin	plasmin	VBD	0
generated	generated	VBN	0
from	from	IN	0
plasminogen	plasminogen	NN	B-NP
by	by	IN	0
plasminogen	plasminogen	JJ	B-NP
activator	activator	NN	I-NP
(	(	-LRB-	0
PA	PA	NNP	B-NP
)	)	-RRB-	0
degrades	degrades	VBZ	0
much	much	RB	0
of	of	IN	0
the	the	DT	0
fibronectin	fibronectin	NN	B-NP
.	.	.	0
To	To	TO	0
investigate	investigate	VB	0
whether	whether	IN	0
activity	activity	NN	0
of	of	IN	0
PA	PA	NNP	0
might	might	MD	0
be	be	VB	0
decreased	decreased	VBN	0
with	with	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
leading	leading	VBG	0
to	to	TO	0
fibronectin	fibronectin	NN	B-NP
accumulation	accumulation	VB	I-NP
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
PA	PA	NNP	0
activity	activity	NN	0
.	.	.	0
Our	Our	PRP$	0
results	results	NNS	0
showed	showed	VBD	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
detectable	detectable	JJ	0
PA	PA	NNP	0
activity	activity	NN	0
in	in	IN	0
untreated	untreated	NN	0
or	or	CC	0
treated	treated	JJ	0
fibroblast	fibroblast	NN	B-NP
whereas	whereas	IN	0
the	the	DT	0
activity	activity	NN	0
is	is	VBZ	0
high	high	JJ	0
in	in	IN	0
rsv-transformed	rsv-transformed	NN	B-NP
cef	cef	NN	I-NP
(	(	-LRB-	0
tcef	tcef	NN	B-NP
;	;	:	0
Fig.	Fig.	CD	0
5A	5A	CD	0
)	)	-RRB-	0
which	which	WDT	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
produce	produce	VB	0
high	high	JJ	0
levels	levels	NNS	0
of	of	IN	0
PA	PA	NNP	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
PA	PA	NNP	0
does	does	VBZ	0
not	not	RB	0
appear	appear	VB	0
to	to	TO	0
be	be	VB	0
activated	activated	VBN	0
by	by	IN	0
cCAF	cCAF	NNP	B-NP
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
the	the	DT	0
stability	stability	NN	0
of	of	IN	0
fibronectin	fibronectin	NN	B-NP
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
MMP	MMP	NNP	B-NP
production	production	NN	I-NP
/	/	CD	I-NP
activation	activation	NN	I-NP
.	.	.	0
In	In	IN	0
humans	humans	NNS	0
,	,	,	0
MMP-3	MMP-3	NNP	B-NP
,	,	,	0
MMP-7	MMP-7	NNP	B-NP
and	and	CC	0
MMP-10	MMP-10	NNP	B-NP
(	(	-LRB-	0
stromelysin	stromelysin	NN	B-NP
)	)	-RRB-	0
are	are	VBP	0
the	the	DT	0
most	most	RBS	0
active	active	JJ	0
fibronectin	fibronectin	NN	B-NP
protea	protea	NN	I-NP
,	,	,	0
but	but	CC	0
these	these	DT	0
molecules	molecules	NNS	0
have	have	VBP	0
not	not	RB	0
been	been	VBN	0
isolated	isolated	VBN	0
in	in	IN	0
chickens	chickens	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
we	we	PRP	0
can	can	MD	0
test	test	VB	0
for	for	IN	0
general	general	JJ	0
activity	activity	NN	0
of	of	IN	0
these	these	DT	0
MMPs	MMPs	JJ	0
in	in	IN	0
the	the	DT	0
chicken	chicken	NN	0
system	system	NN	0
by	by	IN	0
zymography	zymography	NN	B-NP
using	using	VBG	0
casein	casein	NN	B-NP
as	as	IN	0
substrate	substrate	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
Whereas	Whereas	IN	0
the	the	DT	0
positive	positive	JJ	B-NP
control	control	NN	I-NP
(	(	-LRB-	0
trypsin	trypsin	LS	B-NP
)	)	-RRB-	0
was	was	VBD	0
able	able	JJ	0
to	to	TO	0
digest	digest	VB	0
the	the	DT	0
substrate	substrate	NN	0
at	at	IN	0
specific	specific	JJ	0
sites	sites	NNS	0
in	in	IN	0
the	the	DT	0
gel	gel	NN	B-NP
,	,	,	0
the	the	DT	0
supernatant	supernatant	NN	B-NP
of	of	IN	0
our	our	PRP$	0
treated	treated	JJ	0
fibroblast	fibroblast	NN	B-NP
did	did	VBD	0
not	not	RB	0
.	.	.	0
This	This	DT	0
suggests	suggests	VBZ	0
that	that	IN	0
the	the	DT	0
stromelysin	stromelysin	NN	B-NP
are	are	VBP	0
not	not	RB	0
active	active	JJ	0
in	in	IN	0
this	this	DT	0
system	system	NN	0
or	or	CC	0
that	that	IN	0
our	our	PRP$	0
test	test	NN	0
is	is	VBZ	0
not	not	RB	0
sensitive	sensitive	JJ	0
enough	enough	NN	0
.	.	.	0
To	To	TO	0
further	further	RB	0
investigate	investigate	VB	0
whether	whether	IN	0
matrix	matrix	NN	B-NP
metalloproteinase	metalloproteinase	NN	I-NP
are	are	VBP	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
fibronectin	fibronectin	NN	B-NP
ccaf	ccaf	NN	I-NP
induced	induced	JJ	I-NP
high	high	JJ	I-NP
level	level	JJ	I-NP
will	will	MD	0
require	require	VB	0
evaluation	evaluation	NN	0
of	of	IN	0
matrix-degrading	matrix-degrading	JJ	0
enzymes	enzymes	JJ	0
specific	specific	JJ	0
for	for	IN	0
chickens	chickens	NNS	0
and	and	CC	0
is	is	VBZ	0
an	an	DT	0
ongoing	ongoing	JJ	0
project	project	NN	B-NP
in	in	IN	0
our	our	PRP$	0
laboratory	laboratory	NN	0
as	as	IN	0
we	we	PRP	0
obtain	obtain	VBP	0
/	/	RB	0
develop	develop	VB	0
probes	probes	NNS	0
for	for	IN	0
theses	theses	JJ	0
matrix	matrix	NN	B-NP
metalloproteinase	metalloproteinase	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
another	another	DT	0
possible	possible	JJ	0
mechanism	mechanism	NN	0
for	for	IN	0
the	the	DT	0
cCAF-induced	cCAF-induced	JJ	B-NP
FN	FN	NNP	I-NP
accumulation	accumulation	NN	I-NP
could	could	MD	0
be	be	VB	0
linked	linked	VBN	0
to	to	TO	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
tenascin	tenascin	NN	B-NP
.	.	.	0
tn-c	tn-c	NN	B-NP
knockout	knockout	NN	I-NP
mouse	mouse	NN	I-NP
show	show	VBP	0
fibronectin	fibronectin	NN	B-NP
decreased	decreased	VBN	I-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
wounded	wounded	JJ	0
tissue	tissue	NN	0
and	and	CC	0
this	this	DT	0
decrease	decrease	NN	0
has	has	VBZ	0
been	been	VBN	0
hypothesized	hypothesized	VBN	0
to	to	TO	0
be	be	VB	0
due	due	JJ	0
to	to	TO	0
fibronectin	fibronectin	NN	B-NP
disrupted	disrupted	VB	I-NP
incorporation	incorporation	VBN	I-NP
into	into	IN	0
the	the	DT	0
matrix	matrix	NN	B-NP
in	in	IN	0
the	the	DT	0
tn-c	tn-c	NN	B-NP
absence	absence	NN	I-NP
[	[	-LRB-	0
32	32	CD	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
cCAF-induced	cCAF-induced	NNP	B-NP
TN	TN	NNP	I-NP
production	production	NN	I-NP
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
fibronectin	fibronectin	NN	B-NP
observed	observed	VBD	0
after	after	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
we	we	PRP	0
used	used	VBD	0
antisense	antisense	JJ	B-NP
phosphothioated	phosphothioated	JJ	I-NP
oligonucleotide	oligonucleotide	NN	I-NP
to	to	TO	0
inhibit	inhibit	VB	0
TN	TN	JJ	B-NP
production	production	NN	I-NP
.	.	.	0
sense	sense	NN	B-NP
oligonucleotide	oligonucleotide	NN	I-NP
did	did	VBD	0
not	not	RB	0
have	have	VB	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
cCAF-induced	cCAF-induced	NNP	B-NP
TN	TN	NNP	I-NP
or	or	CC	0
FN	FN	NNP	B-NP
production	production	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
antisense	antisense	JJ	B-NP
oligonucleotide	oligonucleotide	NN	I-NP
were	were	VBD	0
able	able	JJ	0
to	to	TO	0
significantly	significantly	RB	0
decrease	decrease	VB	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
both	both	DT	0
tenascin	tenascin	NN	B-NP
and	and	CC	0
fibronectin	fibronectin	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5C	5C	NNP	0
)	)	-RRB-	0
.	.	.	0
Effects	Effects	NNS	0
of	of	IN	0
cCAF	cCAF	JJ	0
and	and	CC	0
its	its	PRP$	0
peptide	peptide	NN	B-NP
on	on	IN	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
coll	coll	NNP	B-NP
I	I	NNP	0
and	and	CC	0
III	III	NNP	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
cCAF	cCAF	JJ	0
stimulates	stimulates	JJ	0
fibroblast	fibroblast	NN	B-NP
to	to	TO	0
produce	produce	VB	0
coll	coll	NNP	B-NP
increased	increased	VBN	I-NP
level	level	JJ	I-NP
I	I	NNP	0
and	and	CC	0
III	III	NNP	0
,	,	,	0
we	we	PRP	0
treated	treated	VBD	0
cultures	cultures	NNS	0
as	as	IN	0
for	for	IN	0
tenascin	tenascin	NN	B-NP
.	.	.	0
Immunoblot	Immunoblot	JJ	B-NP
analysis	analysis	NN	I-NP
for	for	IN	0
Coll	Coll	NNP	0
I	I	PRP	0
showed	showed	VBD	0
that	that	IN	0
cCAF	cCAF	NNP	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
the	the	DT	0
N-	N-	JJ	0
or	or	CC	0
c-peptide	c-peptide	NN	B-NP
,	,	,	0
caused	caused	VBD	0
a	a	DT	0
small	small	JJ	0
increase	increase	NN	0
in	in	IN	0
Coll	Coll	NNP	0
I	I	NNP	0
protein	protein	NN	B-NP
level	level	JJ	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
6A	6A	NNP	0
)	)	-RRB-	0
.	.	.	0
Probing	Probing	VBG	0
the	the	DT	0
same	same	JJ	0
blots	blots	NN	0
for	for	IN	0
Coll	Coll	NNP	0
III	III	NNP	0
revealed	revealed	VBD	0
no	no	DT	0
cCAF-induced	cCAF-induced	JJ	B-NP
difference	difference	NN	I-NP
in	in	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
production	production	NN	0
of	of	IN	0
this	this	DT	0
protein	protein	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
6B	6B	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
Coll	Coll	NNP	0
I	I	PRP	0
was	was	VBD	0
also	also	RB	0
slightly	slightly	RB	0
increased	increased	VBN	0
by	by	IN	0
treatment	treatment	NN	0
with	with	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
at	at	IN	0
3	3	CD	0
days	days	NNS	0
after	after	IN	0
wounding	wounding	NN	0
but	but	CC	0
did	did	VBD	0
not	not	RB	0
increase	increase	VB	0
to	to	TO	0
higher	higher	JJR	0
levels	levels	NNS	0
than	than	IN	0
the	the	DT	0
control	control	NN	0
at	at	IN	0
7	7	CD	0
days	days	NNS	0
,	,	,	0
whereas	whereas	IN	0
the	the	DT	0
same	same	JJ	0
blots	blots	JJ	0
probed	probed	NN	0
for	for	IN	0
Coll	Coll	NNP	0
III	III	NNP	0
showed	showed	VBD	0
similar	similar	JJ	0
levels	levels	NNS	0
in	in	IN	0
treated	treated	VBN	0
and	and	CC	0
control	control	NN	0
at	at	IN	0
both	both	DT	0
3	3	CD	0
and	and	CC	0
7	7	CD	0
days	days	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
6C	6C	NNP	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
effect	effect	NN	0
on	on	IN	0
Coll	Coll	NNP	0
I	I	PRP	0
could	could	MD	0
be	be	VB	0
due	due	JJ	0
to	to	TO	0
remodeling	remodeling	VB	0
of	of	IN	0
this	this	DT	0
protein	protein	NN	B-NP
by	by	IN	0
proteases	proteases	JJ	B-NP
induced	induced	NN	I-NP
by	by	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
whether	whether	IN	0
cCAF	cCAF	NNP	B-NP
affects	affects	VBZ	0
the	the	DT	0
production	production	NN	0
or	or	CC	0
activity	activity	NN	0
of	of	IN	0
the	the	DT	0
gelatinases	gelatinases	JJ	B-NP
MMP-2	MMP-2	NN	I-NP
or	or	CC	0
MMP-9	MMP-9	NNP	B-NP
,	,	,	0
or	or	CC	0
the	the	DT	0
collagenase	collagenase	JJ	B-NP
MMP-1	MMP-1	NN	I-NP
,	,	,	0
all	all	DT	0
of	of	IN	0
which	which	WDT	0
digest	digest	VBP	0
collagens	collagens	VBG	0
I	I	PRP	0
and	and	CC	0
III	III	NNP	0
.	.	.	0
Using	Using	VBG	B-NP
zymography	zymography	NN	I-NP
,	,	,	0
we	we	PRP	0
found	found	VBD	0
that	that	DT	0
treatment	treatment	NN	0
with	with	IN	0
cCAF	cCAF	JJ	0
or	or	CC	0
the	the	DT	0
peptide	peptide	NN	B-NP
does	does	VBZ	0
not	not	RB	0
alter	alter	VB	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
proMMP-2	proMMP-2	NNP	B-NP
and	and	CC	0
there	there	EX	0
was	was	VBD	0
no	no	DT	0
detectable	detectable	JJ	0
levels	levels	NNS	0
of	of	IN	0
proMMP-9	proMMP-9	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
7A	7A	NNP	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
immunoblot	immunoblot	JJ	B-NP
analysis	analysis	NN	I-NP
using	using	VBG	0
a	a	DT	0
polyclonal	polyclonal	JJ	B-NP
antibody	antibody	NN	I-NP
to	to	TO	0
human	human	JJ	0
MMP-1	MMP-1	NNP	B-NP
(	(	-LRB-	0
this	this	DT	0
reagent	reagent	NN	B-NP
is	is	VBZ	0
not	not	RB	0
available	available	JJ	0
for	for	IN	0
the	the	DT	0
chicken	chicken	NN	B-NP
homologue	homologue	NN	I-NP
of	of	IN	0
this	this	DT	0
matrix	matrix	JJ	B-NP
metalloproteinase	metalloproteinase	NN	I-NP
)	)	-RRB-	0
showed	showed	VBD	0
that	that	DT	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
caused	caused	VBD	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
the	the	DT	0
collagenase	collagenase	JJ	B-NP
MMP-1	MMP-1	NN	I-NP
detected	detected	VBD	0
,	,	,	0
but	but	CC	0
neither	neither	DT	0
TIMP-1	TIMP-1	NNP	B-NP
nor	nor	CC	0
TIMP-2	TIMP-2	NNP	B-NP
(	(	-LRB-	0
two	two	CD	0
natural	natural	JJ	0
inhibitors	inhibitors	NN	0
of	of	IN	0
these	these	DT	0
MMPs	MMPs	JJ	0
)	)	-RRB-	0
levels	levels	NNS	0
were	were	VBD	0
changed	changed	VBN	0
,	,	,	0
as	as	RB	0
evaluated	evaluated	VBN	0
by	by	IN	0
immunoblot	immunoblot	JJ	B-NP
analysis	analysis	NN	I-NP
with	with	IN	0
a	a	DT	0
monoclonal	monoclonal	JJ	B-NP
antibody	antibody	NN	I-NP
to	to	TO	0
the	the	DT	0
corresponding	corresponding	JJ	0
human	human	JJ	0
proteins	proteins	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
7B	7B	NNP	0
)	)	-RRB-	0
.	.	.	0
Effects	Effects	NNS	0
of	of	IN	0
cCAF	cCAF	JJ	0
on	on	IN	0
migration	migration	NN	0
of	of	IN	0
fibroblast	fibroblast	NN	B-NP
During	During	IN	0
healing	healing	NN	0
,	,	,	0
fibroblasts	fibroblasts	JJ	0
migrate	migrate	NN	0
into	into	IN	0
and	and	CC	0
within	within	IN	0
the	the	DT	0
wounded	wounded	JJ	0
tissue	tissue	NN	0
and	and	CC	0
lay	lay	VB	0
down	down	RP	0
the	the	DT	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
that	that	WDT	0
forms	forms	VBZ	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
.	.	.	0
These	These	DT	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
,	,	,	0
especially	especially	RB	0
tenascin	tenascin	NN	B-NP
and	and	CC	0
fibronectin	fibronectin	NN	B-NP
together	together	RB	0
,	,	,	0
stimulate	stimulate	JJ	0
cell	cell	NN	0
migration	migration	NN	0
,	,	,	0
thereby	thereby	RB	0
facilitating	facilitating	VBG	0
the	the	DT	0
entrance	entrance	NN	0
and	and	CC	0
movement	movement	NN	0
of	of	IN	0
additional	additional	JJ	0
fibroblast	fibroblast	NN	B-NP
and	and	CC	0
of	of	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
into	into	IN	0
the	the	DT	0
wound	wound	JJ	B-NP
tissue	tissue	NN	I-NP
.	.	.	0
Because	Because	IN	0
tissues	tissues	NNS	0
treated	treated	VBN	0
with	with	IN	0
cCAF	cCAF	NN	B-NP
have	have	VBP	0
more	more	JJR	0
fibronectin	fibronectin	NN	B-NP
and	and	CC	0
tenascin	tenascin	NN	B-NP
at	at	IN	0
the	the	DT	0
time	time	NN	0
that	that	IN	0
these	these	DT	0
cells	cells	NNS	0
are	are	VBP	0
entering	entering	VBG	0
the	the	DT	0
wound	wound	NN	0
and	and	CC	0
chemokine	chemokine	NN	B-NP
are	are	VBP	0
well	well	RB	0
known	known	VBN	0
for	for	IN	0
their	their	PRP$	0
chemoattractant	chemoattractant	JJ	B-NP
property	property	NN	I-NP
[	[	-LRB-	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
whether	whether	IN	0
cCAF	cCAF	JJ	0
stimulates	stimulates	JJ	0
fibroblast	fibroblast	NN	B-NP
chemotaxi	chemotaxi	NN	I-NP
using	using	VBG	0
transwell	transwell	JJ	B-NP
assay	assay	NN	I-NP
.	.	.	0
To	To	TO	0
avoid	avoid	VB	0
effects	effects	NNS	0
of	of	IN	0
gravity	gravity	NN	B-NP
on	on	IN	0
cell	cell	NN	0
migration	migration	NN	0
,	,	,	0
the	the	DT	0
top	top	JJ	0
chamber	chamber	NN	0
was	was	VBD	0
inverted	inverted	VBN	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
plated	plated	VBN	0
on	on	IN	0
the	the	DT	0
underside	underside	NN	0
of	of	IN	0
the	the	DT	0
membrane	membrane	NN	0
,	,	,	0
allowed	allowed	VBN	0
to	to	TO	0
adhere	adhere	VB	0
to	to	TO	0
it	it	PRP	0
and	and	CC	0
then	then	RB	0
the	the	DT	0
chamber	chamber	NN	0
was	was	VBD	0
turned	turned	VBN	0
right	right	JJ	0
side	side	NN	0
up	up	RB	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
incubated	incubated	JJ	0
overnight	overnight	JJ	0
in	in	IN	0
standard	standard	JJ	0
medium	medium	NN	0
to	to	TO	0
allow	allow	VB	0
expression	expression	NN	0
of	of	IN	0
the	the	DT	0
ccaf	ccaf	NN	B-NP
receptor	receptor	NN	I-NP
and	and	CC	0
the	the	DT	0
following	following	JJ	0
day	day	NN	B-NP
cCAF	cCAF	NN	I-NP
was	was	VBD	0
applied	applied	VBN	0
at	at	IN	0
increasing	increasing	VBG	B-NP
dose	dose	NN	I-NP
(	(	-LRB-	0
100-1000	100-1000	FW	0
ng	ng	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
)	)	-RRB-	0
to	to	TO	0
the	the	DT	0
top	top	JJ	0
chamber	chamber	NN	0
only	only	RB	0
.	.	.	0
The	The	DT	0
migration	migration	JJ	B-NP
assay	assay	NN	I-NP
were	were	VBD	0
carried	carried	VBN	0
out	out	RP	0
for	for	IN	0
24	24	CD	0
hr	hr	NN	B-NP
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	DT	0
fibroblast	fibroblast	NN	B-NP
ccaf	ccaf	NN	I-NP
stimulated	stimulated	JJ	I-NP
migration	migration	NN	I-NP
up	up	IN	0
the	the	DT	0
concentration	concentration	NN	B-NP
gradient	gradient	NN	I-NP
in	in	IN	0
a	a	DT	0
dose-dependent	dose-dependent	JJ	B-NP
manner	manner	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
8A	8A	NNP	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
test	test	VB	0
whether	whether	IN	0
the	the	DT	0
cCAF-induced	cCAF-induced	JJ	B-NP
effect	effect	NN	I-NP
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
chemotaxis	chemotaxis	VB	0
,	,	,	0
we	we	PRP	0
repeated	repeated	VBD	0
the	the	DT	0
transwell	transwell	JJ	B-NP
assay	assay	NN	I-NP
and	and	CC	0
compared	compared	VBN	0
cell	cell	NN	0
migration	migration	NN	0
when	when	WRB	0
cCAF	cCAF	NNP	B-NP
is	is	VBZ	0
added	added	VBN	0
to	to	TO	0
both	both	DT	0
wells	wells	NNS	0
.	.	.	0
Placing	Placing	VBG	0
cCAF	cCAF	JJ	0
in	in	IN	0
both	both	DT	0
wells	wells	NNS	0
abrogated	abrogated	JJ	0
cell	cell	NN	0
migration	migration	NN	0
,	,	,	0
strongly	strongly	RB	0
suggesting	suggesting	VBG	0
that	that	IN	0
this	this	DT	0
fibroblast	fibroblast	NN	B-NP
protein	protein	NN	I-NP
chemoattract	chemoattract	NN	I-NP
(	(	-LRB-	0
Fig	Fig	NNP	0
8B	8B	NNP	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
also	also	RB	0
tested	tested	VBN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
on	on	IN	0
migration	migration	NN	0
by	by	IN	0
using	using	VBG	0
the	the	DT	0
cloning	cloning	JJ	B-NP
ring	ring	NN	I-NP
assay	assay	NN	I-NP
.	.	.	0
In	In	IN	0
a	a	DT	0
specified	specified	JJ	0
length	length	NN	0
of	of	IN	0
time	time	NN	0
,	,	,	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
cCAF	cCAF	NNP	B-NP
moved	moved	VBD	0
a	a	DT	0
longer	longer	JJR	0
distance	distance	NN	0
than	than	IN	0
did	did	JJ	0
control	control	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
corroborating	corroborating	VBG	0
the	the	DT	0
previous	previous	JJ	0
results	results	NNS	0
that	that	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
stimulates	stimulates	FW	0
cell	cell	NN	B-NP
motility	motility	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
8C	8C	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
situ	situ	JJ	0
hybridization	hybridization	NN	0
for	for	IN	0
cCAF	cCAF	NNP	0
showed	showed	VBD	0
that	that	IN	0
the	the	DT	0
migrating	migrating	JJ	0
fibroblasts	fibroblasts	NNS	0
also	also	RB	0
express	express	VB	0
higher	higher	JJR	0
levels	levels	NNS	0
of	of	IN	0
cCAF	cCAF	NNP	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
8D	8D	NNP	0
see	see	VBP	0
also	also	RB	0
ref.	ref.	CD	0
[	[	-LRB-	0
36	36	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
Discussion	Discussion	NN	0
The	The	DT	0
work	work	NN	0
presented	presented	VBD	0
here	here	RB	0
shows	shows	VBZ	0
that	that	DT	0
cCAF	cCAF	JJ	0
,	,	,	0
the	the	DT	0
IL-8	IL-8	NN	B-NP
of	of	IN	0
chickens	chickens	NNS	0
,	,	,	0
stimulates	stimulates	JJ	0
expression	expression	NN	0
of	of	IN	0
several	several	JJ	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
important	important	JJ	0
in	in	IN	0
development	development	NN	0
of	of	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
.	.	.	0
We	We	PRP	0
show	show	VBP	0
that	that	IN	0
:	:	:	0
(	(	-LRB-	0
i	i	FW	0
)	)	-RRB-	0
cCAF	cCAF	NN	B-NP
stimulates	stimulates	FW	0
TN	TN	NN	B-NP
expression	expression	NN	I-NP
and	and	CC	0
that	that	IN	0
a	a	DT	0
15	15	CD	0
amino	amino	JJ	B-NP
acid	acid	NN	I-NP
peptide	peptide	VBP	0
containing	containing	VBG	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
sequence	sequence	NN	I-NP
causes	causes	VBZ	0
the	the	DT	0
same	same	JJ	0
effects	effects	NNS	0
as	as	IN	0
the	the	DT	0
whole	whole	JJ	0
molecule	molecule	NN	B-NP
;	;	:	0
(	(	-LRB-	0
ii	ii	LS	0
)	)	-RRB-	0
in	in	IN	0
contrast	contrast	NN	0
to	to	TO	0
its	its	PRP$	0
effects	effects	NNS	0
on	on	IN	0
TN	TN	NNP	B-NP
production	production	NN	I-NP
,	,	,	0
cCAF-induced	cCAF-induced	JJ	B-NP
increase	increase	NN	I-NP
in	in	IN	0
fibronectin	fibronectin	NN	B-NP
and	and	CC	0
Coll	Coll	NNP	0
I	I	NNP	0
accumulation	accumulation	NN	B-NP
requires	requires	VBZ	0
the	the	DT	0
whole	whole	JJ	0
molecule	molecule	NN	B-NP
;	;	:	0
(	(	-LRB-	0
iii	iii	LS	0
)	)	-RRB-	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
FN	FN	NNP	B-NP
protein	protein	NN	I-NP
is	is	VBZ	0
not	not	RB	0
a	a	DT	0
result	result	NN	0
of	of	IN	0
a	a	DT	0
corresponding	corresponding	JJ	0
increase	increase	NN	0
in	in	IN	0
mRNA	mRNA	NNP	B-NP
,	,	,	0
or	or	CC	0
increase	increase	NN	0
in	in	IN	0
MMP	MMP	NNP	B-NP
production	production	NN	I-NP
or	or	CC	0
PA	PA	NNP	0
activity	activity	NN	0
but	but	CC	0
appears	appears	VBZ	0
to	to	TO	0
be	be	VB	0
linked	linked	VBN	B-NP
TN	TN	NNP	I-NP
production	production	NN	I-NP
;	;	:	0
(	(	-LRB-	0
iv	iv	LS	0
)	)	-RRB-	0
increase	increase	NN	0
in	in	IN	0
Coll	Coll	NNP	0
I	I	PRP	0
correlates	correlates	VBD	0
with	with	IN	0
decreased	decreased	JJ	0
levels	levels	NNS	0
of	of	IN	0
MMP-1	MMP-1	CD	B-NP
;	;	:	0
(	(	-LRB-	0
v	v	LS	0
)	)	-RRB-	0
ccaf	ccaf	NN	B-NP
chemoattracts	chemoattracts	JJ	I-NP
fibroblast	fibroblast	NN	I-NP
and	and	CC	0
accelerates	accelerates	VBZ	0
their	their	PRP$	0
migration	migration	NN	0
;	;	:	0
(	(	-LRB-	0
vi	vi	LS	B-NP
)	)	-RRB-	0
treatment	treatment	NN	0
of	of	IN	0
excision	excision	JJ	B-NP
wound	wound	NN	I-NP
with	with	IN	0
cCAF	cCAF	NNP	B-NP
increased	increased	VBD	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
all	all	DT	0
three	three	CD	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
of	of	IN	0
wounds	wounds	NNS	0
albeit	albeit	IN	0
with	with	IN	0
different	different	JJ	0
dynamics	dynamics	NNS	0
.	.	.	0
This	This	DT	0
is	is	VBZ	0
the	the	DT	0
first	first	JJ	0
demonstration	demonstration	NN	B-NP
that	that	IN	0
treatment	treatment	NN	0
of	of	IN	0
wounds	wounds	NNS	0
with	with	IN	0
a	a	DT	0
pro-inflammatory	pro-inflammatory	JJ	0
and	and	CC	0
angiogenic	angiogenic	JJ	B-NP
chemokine	chemokine	NN	I-NP
accelerates	accelerates	VBZ	0
development	development	NN	0
of	of	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
during	during	IN	0
healing	healing	NN	0
by	by	IN	0
stimulating	stimulating	VBG	0
the	the	DT	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
precocious	precocious	JJ	I-NP
deposition	deposition	NN	I-NP
that	that	WDT	0
are	are	VBP	0
critical	critical	JJ	0
for	for	IN	0
proper	proper	JJ	0
healing	healing	NN	0
.	.	.	0
We	We	PRP	0
showed	showed	VBD	0
previously	previously	RB	0
that	that	IN	0
cCAF	cCAF	NNP	B-NP
is	is	VBZ	0
highly	highly	RB	0
expressed	expressed	VBN	0
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
of	of	IN	0
wounds	wounds	NNS	0
[	[	-LRB-	0
6	6	CD	0
36	36	CD	0
]	]	-RRB-	0
,	,	,	0
that	that	IN	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
and	and	CC	0
several	several	JJ	0
of	of	IN	0
its	its	PRP$	0
human	human	JJ	0
homologues	homologues	JJ	0
stimulate	stimulate	JJ	0
fibroblast	fibroblast	NN	B-NP
differentiation	differentiation	NN	I-NP
into	into	IN	0
myofibroblasts	myofibroblasts	VBG	0
both	both	DT	0
in	in	IN	0
culture	culture	NN	0
and	and	CC	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
the	the	DT	0
latter	latter	JJ	0
effect	effect	NN	0
can	can	MD	0
be	be	VB	0
achieved	achieved	VBN	0
very	very	RB	0
effectively	effectively	RB	0
by	by	IN	0
the	the	DT	0
N-terminal	N-terminal	JJ	0
15aas	15aas	NN	0
of	of	IN	0
the	the	DT	0
protein	protein	NN	B-NP
[	[	-LRB-	0
4	4	CD	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
cCAF	cCAF	JJ	0
,	,	,	0
other	other	JJ	0
CXC	CXC	NN	0
chemokine	chemokine	NN	B-NP
have	have	VBP	0
been	been	VBN	0
associated	associated	VBN	0
with	with	IN	0
wound	wound	JJ	B-NP
healing	healing	NN	I-NP
event	event	NN	I-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
burn	burn	JJ	B-NP
wound	wound	NN	I-NP
granulation	granulation	JJ	I-NP
tissue	tissue	NN	I-NP
,	,	,	0
expression	expression	NN	0
of	of	IN	0
groα	groα	JJ	0
/	/	NNP	0
MGSA	MGSA	NNP	B-NP
and	and	CC	0
CXCR2	CXCR2	NNP	B-NP
(	(	-LRB-	0
the	the	DT	0
mgsa	mgsa	NN	B-NP
receptor	receptor	NN	I-NP
)	)	-RRB-	0
was	was	VBD	0
associated	associated	VBN	0
with	with	IN	0
fibroblast	fibroblast	NN	B-NP
,	,	,	0
smooth	smooth	JJ	0
muscle	muscle	NN	B-NP
cells/myofibroblast	cells/myofibroblast	NN	I-NP
and	and	CC	0
a	a	DT	0
macrophage	macrophage	NN	B-NP
subpopulation	subpopulation	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
Groα	Groα	NNP	B-NP
/	/	NNP	I-NP
MGSA	MGSA	NNP	I-NP
and	and	CC	0
IL-8	IL-8	NNP	B-NP
have	have	VBP	0
also	also	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
enhance	enhance	VB	0
re-epithelialization	re-epithelialization	JJ	B-NP
of	of	IN	0
human	human	JJ	0
skin	skin	NN	0
grafts	grafts	NN	0
in	in	IN	0
chimeric	chimeric	JJ	B-NP
mouse	mouse	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
found	found	VBN	0
that	that	IN	0
several	several	JJ	0
CXC	CXC	NNP	0
chemokine	chemokine	NN	B-NP
can	can	MD	0
modulate	modulate	VB	0
angiogenesi	angiogenesi	NN	B-NP
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
,	,	,	0
a	a	DT	0
process	process	NN	0
that	that	WDT	0
is	is	VBZ	0
critical	critical	JJ	0
for	for	IN	0
proper	proper	JJ	0
healing	healing	NN	0
.	.	.	0
Some	Some	DT	0
CXC	CXC	NNP	0
chemokine	chemokine	NN	B-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
IL-8	IL-8	NNP	B-NP
and	and	CC	0
cCAF	cCAF	JJ	0
,	,	,	0
are	are	VBP	0
angiogenic	angiogenic	VBN	0
in	in	IN	0
vivo	vivo	NN	B-NP
[	[	-LRB-	0
3	3	CD	0
39	39	CD	0
40	40	CD	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
Others	Others	NNS	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
IP-10	IP-10	NNP	B-NP
(	(	-LRB-	0
interferon-γ10	interferon-γ10	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
platelet	platelet	NN	B-NP
factor	factor	NN	I-NP
4	4	NN	I-NP
(	(	-LRB-	0
platelet	platelet	NN	B-NP
factor-4	factor-4	NN	I-NP
)	)	-RRB-	0
,	,	,	0
are	are	VBP	0
anti-angiogenic	anti-angiogenic	JJ	B-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
IP-10	IP-10	NNP	B-NP
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
in	in	IN	0
transgenic	transgenic	JJ	B-NP
mouse	mouse	NN	I-NP
treated	treated	VBN	0
with	with	IN	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
,	,	,	0
wounds	wounds	NNS	0
heal	heal	VBP	0
poorly	poorly	RB	0
and	and	CC	0
exhibit	exhibit	NN	B-NP
defect	defect	NN	I-NP
in	in	IN	0
angiogenesi	angiogenesi	NN	B-NP
and	and	CC	0
development	development	NN	0
of	of	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
[	[	-LRB-	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
Work	Work	NN	0
of	of	IN	0
others	others	NNS	0
has	has	VBZ	0
shown	shown	VBN	0
that	that	IN	0
tenascin	tenascin	NN	B-NP
is	is	VBZ	0
expressed	expressed	VBN	0
in	in	IN	0
association	association	NN	0
with	with	IN	0
myofibroblast	myofibroblast	NN	B-NP
differentiation	differentiation	NN	I-NP
and	and	CC	0
is	is	VBZ	0
important	important	JJ	0
in	in	IN	0
cell	cell	NN	0
migration	migration	NN	0
during	during	IN	0
healing	healing	NN	0
[	[	-LRB-	0
25	25	CD	0
42	42	CD	0
43	43	CD	0
44	44	CD	0
]	]	-RRB-	0
.	.	.	0
Here	Here	RB	0
we	we	PRP	0
show	show	VBP	0
that	that	IN	0
cCAF	cCAF	JJ	0
and	and	CC	0
the	the	DT	0
N-peptide	N-peptide	JJ	B-NP
stimulate	stimulate	JJ	0
fibroblast	fibroblast	NN	B-NP
in	in	IN	0
culture	culture	NN	0
to	to	TO	0
express	express	VB	0
tenascin	tenascin	NN	B-NP
and	and	CC	0
that	that	IN	0
this	this	DT	0
increase	increase	NN	0
in	in	IN	0
tenascin	tenascin	NN	B-NP
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
mrna	mrna	NN	B-NP
level	level	JJ	I-NP
.	.	.	0
The	The	DT	0
increase	increase	NN	0
is	is	VBZ	0
lower	lower	JJR	0
for	for	IN	0
C-peptide	C-peptide	JJ	B-NP
treated	treated	JJ	0
cells	cells	NNS	0
;	;	:	0
after	after	IN	0
3	3	CD	0
days	days	NNS	0
in	in	IN	0
an	an	DT	0
environment	environment	NN	0
mimicking	mimicking	VBD	0
the	the	DT	0
wound	wound	NN	0
,	,	,	0
these	these	DT	0
cells	cells	NNS	0
had	had	VBD	0
lesser	lesser	JJR	0
but	but	CC	0
significant	significant	JJ	0
tenascin	tenascin	JJ	B-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
,	,	,	0
most	most	RBS	0
likely	likely	JJ	0
due	due	JJ	0
to	to	TO	0
the	the	DT	0
small	small	JJ	0
increase	increase	NN	0
seen	seen	VBN	0
in	in	IN	0
mRNA	mRNA	JJ	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
in	in	IN	0
wounds	wounds	NNS	0
treated	treated	VBN	0
with	with	IN	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
,	,	,	0
tn	tn	NN	B-NP
level	level	JJ	I-NP
are	are	VBP	0
much	much	RB	0
higher	higher	JJR	0
at	at	IN	0
early	early	JJ	0
times	times	NNS	0
after	after	IN	0
wounding	wounding	NN	0
but	but	CC	0
drop	drop	NN	0
by	by	IN	0
7	7	CD	0
days	days	NNS	0
after	after	IN	0
wounding	wounding	NN	0
.	.	.	0
At	At	IN	0
this	this	DT	0
stage	stage	NN	0
,	,	,	0
the	the	DT	0
wounds	wounds	NNS	0
are	are	VBP	0
closed	closed	VBN	0
and	and	CC	0
are	are	VBP	0
beginning	beginning	VBG	0
to	to	TO	0
remodel	remodel	VB	0
in	in	IN	0
the	the	DT	0
ccaf-treated	ccaf-treated	NN	B-NP
wound	wound	NN	I-NP
while	while	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
in	in	IN	0
the	the	DT	0
control	control	NN	B-NP
wing	wing	NN	I-NP
is	is	VBZ	0
still	still	RB	0
maturing	maturing	VBG	0
.	.	.	0
These	These	DT	0
data	data	NNS	0
taken	taken	VBN	0
together	together	RB	0
strongly	strongly	RB	0
suggest	suggest	VB	0
that	that	IN	0
as	as	RB	0
chemokines	chemokines	RB	0
induce	induce	VB	0
the	the	DT	0
fibroblast	fibroblast	NN	B-NP
differentiation	differentiation	NN	I-NP
into	into	IN	0
myofibroblasts	myofibroblasts	VBG	0
they	they	PRP	0
contribute	contribute	VBP	0
to	to	TO	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
tenascin	tenascin	NN	B-NP
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
.	.	.	0
Our	Our	PRP$	0
finding	finding	NN	0
that	that	IN	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
peptide	peptide	NN	I-NP
is	is	VBZ	0
able	able	JJ	0
to	to	TO	0
stimulate	stimulate	VB	0
expression	expression	NN	0
of	of	IN	0
tenascin	tenascin	NN	B-NP
much	much	RB	0
like	like	IN	0
the	the	DT	0
whole	whole	JJ	0
protein	protein	NN	B-NP
is	is	VBZ	0
potentially	potentially	RB	0
important	important	JJ	0
because	because	IN	0
this	this	DT	0
small	small	JJ	0
peptide	peptide	NN	B-NP
may	may	MD	0
be	be	VB	0
useful	useful	JJ	0
to	to	TO	0
develop	develop	VB	0
therapeutic	therapeutic	JJ	B-NP
agonist	agonist	NN	I-NP
or	or	CC	0
antagonists	antagonists	NNS	0
for	for	IN	0
wound	wound	JJ	B-NP
healing	healing	NN	I-NP
.	.	.	0
The	The	DT	0
effect	effect	NN	0
of	of	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
on	on	IN	0
Coll	Coll	NNP	0
I	I	NNP	0
accumulation	accumulation	NN	B-NP
in	in	IN	0
culture	culture	NN	0
and	and	CC	0
in	in	IN	0
wounded	wounded	JJ	0
tissues	tissues	NNS	0
is	is	VBZ	0
small	small	JJ	0
but	but	CC	0
reproducible	reproducible	NN	0
.	.	.	0
Because	Because	IN	0
mmp-1	mmp-1	NN	B-NP
level	level	JJ	I-NP
were	were	VBD	0
also	also	RB	0
decreased	decreased	VBN	0
by	by	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
the	the	DT	0
small	small	JJ	0
rise	rise	NN	0
in	in	IN	0
Coll	Coll	NNP	0
I	I	NNP	0
levels	levels	NNS	0
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
decreased	decreased	VB	B-NP
degradation	degradation	VBN	I-NP
of	of	IN	0
this	this	DT	0
ECM	ECM	NNP	B-NP
molecule	molecule	NN	I-NP
by	by	IN	0
the	the	DT	0
collagenase	collagenase	NN	B-NP
.	.	.	0
Another	Another	DT	0
chemokine	chemokine	NN	B-NP
that	that	WDT	0
has	has	VBZ	0
been	been	VBN	0
associated	associated	VBN	0
with	with	IN	0
Coll	Coll	NNP	0
I	I	NNP	0
production	production	NN	0
is	is	VBZ	0
monocyte	monocyte	JJ	B-NP
chemotactic	chemotactic	JJ	I-NP
protein	protein	NN	I-NP
1	1	CD	0
(	(	-LRB-	0
MCP-1	MCP-1	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
chemokine	chemokine	NN	B-NP
belongs	belongs	VBZ	0
to	to	TO	0
the	the	DT	0
CC	CC	NNP	0
chemokine	chemokine	JJ	B-NP
family	family	NN	I-NP
and	and	CC	0
stimulates	stimulates	JJ	0
Coll	Coll	NNP	0
I	I	NNP	0
production	production	NN	0
both	both	CC	0
by	by	IN	0
lung	lung	NN	0
fibroblasts	fibroblasts	VBZ	0
taken	taken	VBN	0
from	from	IN	0
areas	areas	NNS	0
of	of	IN	0
inflammation	inflammation	NN	B-NP
[	[	-LRB-	0
26	26	CD	0
]	]	-RRB-	0
and	and	CC	0
in	in	IN	0
kidneys	kidneys	NNS	0
that	that	WDT	0
suffer	suffer	VBP	0
from	from	IN	0
crescentic	crescentic	JJ	B-NP
nephritis	nephritis	NN	I-NP
[	[	-LRB-	0
45	45	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
former	former	JJ	0
investigator	investigator	NN	B-NP
reported	reported	VBD	0
that	that	IN	0
collagen	collagen	JJ	B-NP
accumulation	accumulation	NN	I-NP
mcp-1	mcp-1	NN	I-NP
increase	increase	NN	I-NP
not	not	RB	0
by	by	IN	0
decreasing	decreasing	VBG	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
the	the	DT	0
collagenase	collagenase	JJ	B-NP
MMP-1	MMP-1	NN	I-NP
,	,	,	0
but	but	CC	0
by	by	IN	0
stimulating	stimulating	VBG	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
TGFβ1	TGFβ1	NNP	B-NP
,	,	,	0
a	a	DT	0
well-known	well-known	JJ	0
collagen	collagen	JJ	B-NP
expression	expression	NN	I-NP
stimulator	stimulator	NN	I-NP
and	and	CC	0
expression	expression	NN	0
of	of	IN	0
timp	timp	NN	B-NP
,	,	,	0
the	the	DT	0
natural	natural	JJ	0
inhibitors	inhibitors	NN	0
of	of	IN	0
MMPs	MMPs	JJ	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
to	to	TO	0
monocyte	monocyte	NN	B-NP
chemotactic	chemotactic	NN	I-NP
protein	protein	NN	I-NP
1	1	NN	I-NP
,	,	,	0
IL-8	IL-8	NNP	B-NP
and	and	CC	0
MGSA	MGSA	NNP	B-NP
have	have	VBP	0
also	also	RB	0
been	been	VBN	0
evaluated	evaluated	VBN	0
for	for	IN	0
production	production	NN	0
of	of	IN	0
collagen	collagen	NN	B-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
investigator	investigator	NN	B-NP
reported	reported	VBD	0
that	that	DT	0
treatment	treatment	NN	0
of	of	IN	0
normal	normal	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
with	with	IN	0
these	these	DT	0
chemokine	chemokine	NN	B-NP
did	did	VBD	0
not	not	RB	0
affect	affect	VB	0
collagen	collagen	JJ	B-NP
level	level	JJ	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
not	not	RB	0
clear	clear	JJ	0
from	from	IN	0
their	their	PRP$	0
results	results	NNS	0
whether	whether	IN	0
the	the	DT	0
elevation	elevation	NN	0
in	in	IN	0
collagen	collagen	JJ	B-NP
production	production	NN	I-NP
in	in	IN	0
normal	normal	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
may	may	MD	0
have	have	VB	0
been	been	VBN	0
small	small	JJ	0
,	,	,	0
like	like	IN	0
that	that	WDT	0
observed	observed	VBD	0
with	with	IN	0
cCAF	cCAF	NNP	B-NP
,	,	,	0
and	and	CC	0
therefore	therefore	RB	0
gone	gone	VBN	0
unnoticed	unnoticed	NN	0
.	.	.	0
FN	FN	NNP	B-NP
accumulation	accumulation	VBD	I-NP
due	due	JJ	0
to	to	TO	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
also	also	RB	0
differs	differs	VBZ	0
from	from	IN	0
that	that	DT	0
of	of	IN	0
tenascin	tenascin	NN	B-NP
.	.	.	0
The	The	DT	0
fn	fn	NN	B-NP
mrna	mrna	NN	I-NP
level	level	JJ	I-NP
are	are	VBP	0
not	not	RB	0
affected	affected	VBN	0
by	by	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
but	but	CC	0
the	the	DT	0
protein	protein	NN	B-NP
accumulates	accumulates	NN	0
in	in	IN	0
culture	culture	NN	0
and	and	CC	0
in	in	IN	0
the	the	DT	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
of	of	IN	0
wounds	wounds	NNS	0
upon	upon	IN	0
exposure	exposure	NN	0
to	to	TO	0
the	the	DT	0
chemokine	chemokine	NN	B-NP
.	.	.	0
By	By	IN	0
analogy	analogy	NN	0
with	with	IN	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
Coll	Coll	NNP	0
I	I	NNP	0
,	,	,	0
we	we	PRP	0
hypothesized	hypothesized	VBD	0
that	that	DT	0
decrease	decrease	NN	0
in	in	IN	0
protease	protease	JJ	B-NP
level	level	NN	I-NP
/	/	JJ	I-NP
activity	activity	NN	I-NP
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
fibronectin	fibronectin	NN	B-NP
accumulation	accumulation	NN	I-NP
.	.	.	0
Plasmin	Plasmin	RB	0
resulting	resulting	VBG	0
from	from	IN	0
cleavage	cleavage	NN	0
of	of	IN	0
plasminogen	plasminogen	NN	B-NP
by	by	IN	0
plasminogen	plasminogen	JJ	B-NP
activator	activator	NN	I-NP
(	(	-LRB-	0
PA	PA	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
the	the	DT	0
major	major	JJ	0
affecting	affecting	VBG	B-NP
fn	fn	NN	I-NP
degradation	degradation	NN	I-NP
enzyme	enzyme	NNS	I-NP
in	in	IN	0
chickens	chickens	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
testing	testing	VBG	0
for	for	IN	0
decrease	decrease	NN	0
in	in	IN	0
PA	PA	NNP	0
activity	activity	NN	0
showed	showed	VBD	0
that	that	IN	0
this	this	DT	0
enzyme	enzyme	NN	B-NP
is	is	VBZ	0
not	not	RB	0
activated	activated	VBN	0
even	even	RB	0
in	in	IN	0
the	the	DT	0
controls	controls	NNS	0
,	,	,	0
therefore	therefore	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
unlikely	unlikely	JJ	0
that	that	IN	0
this	this	DT	0
would	would	MD	0
be	be	VB	0
a	a	DT	0
major	major	JJ	0
mechanism	mechanism	NN	0
involved	involved	VBN	0
in	in	IN	0
degrading	degrading	JJ	0
fibronectin	fibronectin	NN	B-NP
.	.	.	0
In	In	IN	0
humans	humans	NNS	0
,	,	,	0
there	there	EX	0
are	are	VBP	0
several	several	JJ	0
matrix	matrix	NN	B-NP
metalloproteinase	metalloproteinase	NN	I-NP
that	that	WDT	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
degrade	degrade	VB	0
fibronectin	fibronectin	NN	B-NP
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	IN	0
mmp-2	mmp-2	NN	B-NP
level	level	JJ	I-NP
are	are	VBP	0
unaffected	unaffected	VBN	0
by	by	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
and	and	CC	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
detectable	detectable	JJ	0
MMP-3	MMP-3	NN	B-NP
,	,	,	0
-7	-7	NNP	0
and	and	CC	0
-10	-10	CD	0
activity	activity	NN	0
as	as	IN	0
evaluated	evaluated	NN	0
by	by	IN	0
casein	casein	JJ	B-NP
zymography	zymography	NN	I-NP
using	using	VBG	0
tCEFs	tCEFs	JJ	0
as	as	IN	0
control	control	NN	0
for	for	IN	0
production	production	NN	0
of	of	IN	0
these	these	DT	0
stromelysin	stromelysin	NN	B-NP
.	.	.	0
Another	Another	DT	0
FN-degrading	FN-degrading	JJ	B-NP
metalloproteinase	metalloproteinase	NN	I-NP
,	,	,	0
MT-MMP1	MT-MMP1	NNP	B-NP
,	,	,	0
is	is	VBZ	0
unlikely	unlikely	JJ	0
to	to	TO	0
be	be	VB	0
involved	involved	VBN	0
because	because	IN	0
it	it	PRP	0
also	also	RB	0
activates	activates	JJ	0
MMP-2	MMP-2	NN	B-NP
and	and	CC	0
this	this	DT	0
enzyme	enzyme	NN	B-NP
is	is	VBZ	0
not	not	RB	0
activated	activated	VBN	0
by	by	IN	0
cCAF	cCAF	JJ	B-NP
treatment	treatment	NN	I-NP
.	.	.	0
Another	Another	DT	0
possible	possible	JJ	0
mechanism	mechanism	NN	0
that	that	WDT	0
may	may	MD	0
explain	explain	VB	0
FN	FN	JJ	B-NP
accumulation	accumulation	NN	I-NP
could	could	MD	0
be	be	VB	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
tenascin	tenascin	NN	B-NP
.	.	.	0
tn-c	tn-c	NN	B-NP
knockout	knockout	NN	I-NP
mouse	mouse	NN	I-NP
show	show	VBP	0
fibronectin	fibronectin	NN	B-NP
decreased	decreased	VBN	I-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
wounded	wounded	JJ	0
tissue	tissue	NN	0
and	and	CC	0
this	this	DT	0
decrease	decrease	NN	0
has	has	VBZ	0
been	been	VBN	0
hypothesized	hypothesized	VBN	0
to	to	TO	0
be	be	VB	0
due	due	JJ	0
to	to	TO	0
disrupted	disrupted	VB	B-NP
incorporation	incorporation	VBN	I-NP
on	on	IN	0
fibronectin	fibronectin	NN	B-NP
into	into	IN	0
the	the	DT	0
matrix	matrix	NN	B-NP
in	in	IN	0
the	the	DT	0
tn-c	tn-c	NN	B-NP
absence	absence	NN	I-NP
[	[	-LRB-	0
32	32	CD	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
our	our	PRP$	0
observation	observation	NN	0
that	that	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
cCAF-induced	cCAF-induced	NNP	B-NP
TN	TN	NNP	I-NP
production	production	NN	I-NP
decreases	decreases	VBZ	0
the	the	DT	0
fibronectin	fibronectin	NN	B-NP
accumulation	accumulation	NN	I-NP
supports	supports	VBZ	0
the	the	DT	0
findings	findings	NNS	0
in	in	IN	0
the	the	DT	0
knockout	knockout	JJ	0
mice	mice	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
this	this	DT	0
does	does	VBZ	0
not	not	RB	0
explain	explain	VB	0
the	the	DT	0
unchanged	unchanged	JJ	0
fn	fn	NN	B-NP
level	level	JJ	I-NP
with	with	IN	0
the	the	DT	0
N-peptide	N-peptide	JJ	B-NP
treatment	treatment	NN	I-NP
.	.	.	0
One	One	CD	0
possible	possible	JJ	0
explanation	explanation	NN	0
for	for	IN	0
these	these	DT	0
findings	findings	NNS	0
could	could	MD	0
relate	relate	VB	0
to	to	TO	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
fibronectin	fibronectin	NN	B-NP
does	does	VBZ	0
not	not	RB	0
self-assemble	self-assemble	JJ	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
alterations	alterations	NN	0
in	in	IN	0
the	the	DT	0
activities	activities	NNS	0
of	of	IN	0
integrin	integrin	NN	B-NP
or	or	CC	0
adhesive	adhesive	JJ	B-NP
site	site	NN	I-NP
on	on	IN	0
other	other	JJ	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
induced	induced	VBN	0
by	by	IN	0
the	the	DT	0
whole	whole	JJ	0
cCAF	cCAF	JJ	B-NP
molecule	molecule	NN	I-NP
,	,	,	0
and	and	CC	0
not	not	RB	0
by	by	IN	0
the	the	DT	0
N-peptide	N-peptide	JJ	B-NP
,	,	,	0
could	could	MD	0
affect	affect	VB	0
FN	FN	JJ	B-NP
accumulation	accumulation	NN	I-NP
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
are	are	VBP	0
currently	currently	RB	0
pursuing	pursuing	VBG	B-NP
study	study	NN	I-NP
to	to	TO	0
determine	determine	VB	0
whether	whether	IN	0
adhesion	adhesion	JJ	B-NP
molecule	molecule	NN	I-NP
or	or	CC	0
other	other	JJ	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
play	play	VBP	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
FN	FN	NNP	B-NP
accumulation	accumulation	VBD	I-NP
due	due	JJ	0
to	to	TO	0
cCAF-induced	cCAF-induced	NNP	B-NP
TN	TN	NNP	I-NP
production	production	NN	I-NP
.	.	.	0
Migration	Migration	NNP	0
of	of	IN	0
fibroblast	fibroblast	NN	B-NP
from	from	IN	0
the	the	DT	0
area	area	NN	0
surrounding	surrounding	VBG	0
the	the	DT	0
wound	wound	NN	0
into	into	IN	0
the	the	DT	0
wound	wound	JJ	B-NP
site	site	NN	I-NP
is	is	VBZ	0
critical	critical	JJ	0
in	in	IN	0
order	order	NN	0
for	for	IN	0
remodeling	remodeling	VBG	0
of	of	IN	0
the	the	DT	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
and	and	CC	0
for	for	IN	0
wound	wound	JJ	B-NP
contraction	contraction	NN	I-NP
to	to	TO	0
occur	occur	VB	0
.	.	.	0
tenascin	tenascin	NN	B-NP
and	and	CC	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
especially	especially	RB	0
in	in	IN	0
combination	combination	NN	0
,	,	,	0
promote	promote	VB	0
migration	migration	NNS	0
,	,	,	0
therefore	therefore	RB	0
cCAF	cCAF	JJ	0
may	may	MD	0
facilitate	facilitate	VB	0
fibroblast	fibroblast	JJ	B-NP
migration	migration	NN	I-NP
by	by	IN	0
increasing	increasing	VBG	B-NP
TN	TN	NNP	I-NP
and	and	CC	0
fn	fn	NN	B-NP
level	level	JJ	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
this	this	DT	0
chemokine	chemokine	NN	B-NP
is	is	VBZ	0
also	also	RB	0
able	able	JJ	0
to	to	TO	0
chemoattract	chemoattract	VB	0
fibroblast	fibroblast	NN	B-NP
and	and	CC	0
accelerate	accelerate	VB	0
their	their	PRP$	0
migration	migration	NN	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
these	these	DT	0
molecules	molecules	NN	0
,	,	,	0
strongly	strongly	RB	0
suggesting	suggesting	VBG	0
that	that	IN	0
it	it	PRP	0
contributes	contributes	VBZ	0
to	to	TO	0
fibroblast	fibroblast	VB	0
movement	movement	NN	0
independently	independently	RB	0
of	of	IN	0
the	the	DT	0
deposition	deposition	NN	B-NP
of	of	IN	0
these	these	DT	0
ECM	ECM	NNP	B-NP
molecule	molecule	NN	I-NP
.	.	.	0
These	These	DT	0
findings	findings	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
during	during	IN	0
wound	wound	JJ	B-NP
healing	healing	NN	I-NP
,	,	,	0
cCAF	cCAF	NNP	B-NP
produced	produced	VBD	0
by	by	IN	0
the	the	DT	0
resident	resident	NN	B-NP
fibroblast	fibroblast	NN	I-NP
chemoattracts	chemoattracts	VBP	0
additional	additional	JJ	0
fibroblast	fibroblast	NN	B-NP
that	that	WDT	0
contribute	contribute	VBP	0
to	to	TO	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
these	these	DT	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
,	,	,	0
which	which	WDT	0
then	then	RB	0
support	support	VB	0
migration	migration	VBN	0
of	of	IN	0
both	both	DT	0
fibroblast	fibroblast	NN	B-NP
and	and	CC	0
other	other	JJ	0
cells	cells	NNS	0
in	in	IN	0
the	the	DT	0
wound	wound	JJ	B-NP
tissue	tissue	NN	I-NP
.	.	.	0
TGFβ1	TGFβ1	NNP	B-NP
is	is	VBZ	0
another	another	DT	0
factor	factor	NN	B-NP
known	known	VBN	0
to	to	TO	0
stimulate	stimulate	VB	0
myofibroblast	myofibroblast	JJ	B-NP
differentiation	differentiation	NN	I-NP
,	,	,	0
ECM	ECM	NNP	B-NP
production	production	NN	I-NP
and	and	CC	0
accelerate	accelerate	VB	0
wound	wound	JJ	B-NP
closure	closure	NN	I-NP
and	and	CC	0
healing	healing	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
this	this	DT	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
has	has	VBZ	0
a	a	DT	0
strong	strong	JJ	0
inflammatory	inflammatory	JJ	B-NP
effect	effect	NN	I-NP
that	that	WDT	0
leads	leads	VBZ	0
to	to	TO	0
excess	excess	JJ	0
fibrosis	fibrosis	NN	0
and	and	CC	0
scarring	scarring	NN	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
greatly	greatly	RB	0
coll	coll	NNP	B-NP
increasing	increasing	VBG	I-NP
accumulation	accumulation	NN	I-NP
I	I	NNP	0
and	and	CC	0
III	III	NNP	0
,	,	,	0
TGFβ1	TGFβ1	NNP	B-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
also	also	RB	0
increase	increase	VB	0
fibronectin	fibronectin	NN	B-NP
and	and	CC	0
TN	TN	NNP	B-NP
production.	production.	NNP	I-NP
cCAF	cCAF	NNP	B-NP
(	(	-LRB-	0
and	and	CC	0
maybe	maybe	RB	0
other	other	JJ	0
chemokine	chemokine	NN	B-NP
)	)	-RRB-	0
,	,	,	0
on	on	IN	0
the	the	DT	0
other	other	JJ	0
hand	hand	NN	0
,	,	,	0
may	may	MD	0
have	have	VB	0
a	a	DT	0
subtler	subtler	NN	0
,	,	,	0
more	more	RBR	0
controlled	controlled	JJ	0
effect	effect	NN	0
,	,	,	0
promoting	promoting	VBG	0
the	the	DT	0
earlier	earlier	JJR	0
appearance	appearance	NN	0
of	of	IN	0
a	a	DT	0
normal	normal	JJ	B-NP
granulation	granulation	JJ	I-NP
tissue	tissue	NN	I-NP
without	without	IN	0
leading	leading	VBG	0
to	to	TO	0
excess	excess	JJ	0
matrix	matrix	JJ	B-NP
accumulation	accumulation	NN	I-NP
and	and	CC	0
scarring	scarring	NN	0
.	.	.	0
Conclusions	Conclusions	VBG	0
Our	Our	PRP$	0
results	results	NNS	0
strongly	strongly	RB	0
suggest	suggest	VB	0
that	that	DT	0
cCAF	cCAF	NN	B-NP
plays	plays	VBZ	0
an	an	DT	0
important	important	JJ	0
role	role	NN	0
in	in	IN	0
wound	wound	JJ	B-NP
repair	repair	NN	I-NP
by	by	IN	0
activating	activating	JJ	0
fibroblast	fibroblast	NN	B-NP
to	to	TO	0
form	form	VB	0
early	early	JJ	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
,	,	,	0
through	through	IN	0
cell	cell	NN	0
migration	migration	NN	0
,	,	,	0
myofibroblast	myofibroblast	JJ	B-NP
differentiation	differentiation	NN	I-NP
and	and	CC	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
production/accumulation	production/accumulation	NN	I-NP
that	that	WDT	0
are	are	VBP	0
critical	critical	JJ	0
for	for	IN	0
proper	proper	JJ	0
development	development	NN	0
of	of	IN	0
the	the	DT	0
healing	healing	NN	0
tissue	tissue	NN	0
of	of	IN	0
wounds	wounds	NNS	0
.	.	.	0
This	This	DT	0
is	is	VBZ	0
a	a	DT	0
previously	previously	RB	0
unknown	unknown	JJ	0
role	role	NN	0
for	for	IN	0
chemokine	chemokine	NN	B-NP
and	and	CC	0
,	,	,	0
unlike	unlike	IN	0
other	other	JJ	0
inflammatory	inflammatory	JJ	B-NP
factor	factor	NN	I-NP
that	that	WDT	0
promote	promote	VBP	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
formation	formation	NN	I-NP
,	,	,	0
cCAF	cCAF	NNP	B-NP
does	does	VBZ	0
not	not	RB	0
appear	appear	VB	0
to	to	TO	0
stimulate	stimulate	VB	0
increased	increased	VBN	0
fibrosis	fibrosis	NN	0
.	.	.	0
If	If	IN	0
similar	similar	JJ	0
behavior	behavior	NN	0
is	is	VBZ	0
seen	seen	VBN	0
in	in	IN	0
human	human	JJ	0
chemokine	chemokine	NN	B-NP
,	,	,	0
it	it	PRP	0
could	could	MD	0
be	be	VB	0
a	a	DT	0
promising	promising	JJ	0
target	target	NN	0
in	in	IN	0
designing	designing	VBG	B-NP
drug	drug	NN	I-NP
that	that	IN	0
promote	promote	JJ	0
formation	formation	NN	0
of	of	IN	0
granulation	granulation	JJ	B-NP
tissue	tissue	NN	I-NP
in	in	IN	0
poorly	poorly	RB	0
healing	healing	JJ	0
wounds	wounds	NNS	0
without	without	IN	0
causing	causing	VBG	0
excess	excess	JJ	0
scarring	scarring	NN	0
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
methods	methods	NNS	0
Reagents	Reagents	VBG	0
All	All	DT	0
tissue	tissue	NN	0
culture	culture	NN	0
supplies	supplies	NNS	0
and	and	CC	0
the	the	DT	0
TRIzol	TRIzol	JJ	B-NP
reagent	reagent	NN	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Gibco-BRL.	Gibco-BRL.	NNP	B-NP
cCAF	cCAF	NNP	B-NP
and	and	CC	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
peptida	peptida	NN	I-NP
(	(	-LRB-	0
15a.a.	15a.a.	NNP	0
)	)	-RRB-	0
were	were	VBD	0
synthesized	synthesized	VBN	0
by	by	IN	0
Gryphon	Gryphon	NNP	0
Sciences	Sciences	NNPS	0
(	(	-LRB-	0
San	San	NNP	0
Francisco	Francisco	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
C-terminus	C-terminus	JJ	B-NP
peptida	peptida	NN	I-NP
(	(	-LRB-	0
28a.a	28a.a	NNP	0
)	)	-RRB-	0
was	was	VBD	0
made	made	VBN	0
by	by	IN	0
Milligen	Milligen	NNP	B-NP
Biosearch	Biosearch	NNP	I-NP
(	(	-LRB-	0
San	San	NNP	0
Rafael	Rafael	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
used	used	VBN	0
:	:	:	0
anti-mouse	anti-mouse	JJ	B-NP
and	and	CC	0
anti-rabbit	anti-rabbit	JJ	B-NP
horseradish	horseradish	JJ	I-NP
peroxidase	peroxidase	NN	I-NP
,	,	,	0
anti-mouse	anti-mouse	NNP	B-NP
Texas	Texas	NNP	I-NP
Red	Red	NNP	I-NP
(	(	-LRB-	0
Amersham	Amersham	NNP	B-NP
:	:	:	0
Piscataway	Piscataway	NNP	B-NP
,	,	,	0
neighbor	neighbor	NN	B-NP
joining	joining	VBG	I-NP
)	)	-RRB-	0
and	and	CC	0
anti-mouse	anti-mouse	NNP	B-NP
FITC	FITC	NNP	I-NP
(	(	-LRB-	0
DAKO	DAKO	NNP	B-NP
:	:	:	0
Carpinteria	Carpinteria	NNP	B-NP
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
used	used	VBN	0
:	:	:	0
mouse	mouse	JJ	0
anti-chicken	anti-chicken	JJ	0
Coll	Coll	NNP	0
I	I	NNP	0
,	,	,	0
Coll	Coll	NNP	0
III	III	NNP	0
,	,	,	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
and	and	CC	0
tenascin	tenascin	NN	B-NP
(	(	-LRB-	0
Hybridoma	Hybridoma	NNP	B-NP
Bank	Bank	NNP	I-NP
,	,	,	0
Iowa	Iowa	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
rabbit	rabbit	JJ	B-NP
anti-chicken	anti-chicken	JJ	I-NP
TN	TN	NNP	I-NP
(	(	-LRB-	0
Chemicon	Chemicon	NNP	B-NP
,	,	,	0
Temecula	Temecula	NNP	B-NP
CA	CA	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
Rabbit	Rabbit	NNP	B-NP
anti-human	anti-human	NNP	I-NP
MMP-1	MMP-1	NNP	I-NP
and	and	CC	0
TIMP-2	TIMP-2	NNP	B-NP
and	and	CC	0
mouse	mouse	JJ	B-NP
anti-human	anti-human	JJ	I-NP
TIMP-1	TIMP-1	NN	I-NP
were	were	VBD	0
the	the	DT	0
dr	dr	NN	B-NP
kind	kind	NN	I-NP
gift	gift	NN	I-NP
Tai-Lan	Tai-Lan	NNP	0
Tuan	Tuan	NNP	0
.	.	.	0
The	The	DT	0
ecl	ecl	NN	B-NP
reagent	reagent	NN	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Amersham	Amersham	NNP	B-NP
;	;	:	0
mounting	mounting	VBG	B-NP
medium	medium	NN	I-NP
vectashield	vectashield	NN	I-NP
from	from	IN	0
Vector	Vector	NNP	0
Laboratories	Laboratories	NNPS	0
(	(	-LRB-	0
Burlingame	Burlingame	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
;	;	:	0
DC	DC	NNP	B-NP
protein	protein	NN	I-NP
assay	assay	NN	I-NP
kit	kit	NN	I-NP
from	from	IN	0
Bio-Rad	Bio-Rad	NNP	B-NP
(	(	-LRB-	0
Hercules	Hercules	NNP	0
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
;	;	:	0
Biocoat	Biocoat	NNP	B-NP
and	and	CC	0
transwell	transwell	NN	B-NP
from	from	IN	0
Fisher	Fisher	NNP	0
and	and	CC	0
Biocclusive	Biocclusive	NNP	B-NP
bandage	bandage	NN	I-NP
from	from	IN	0
Johnson	Johnson	NNP	0
&	&	CC	0
Johnson	Johnson	NNP	0
Medical	Medical	NNP	0
(	(	-LRB-	0
Arlington	Arlington	NNP	0
,	,	,	0
TX	TX	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Cell	Cell	NN	0
culture	culture	NN	0
embryonic	embryonic	NN	B-NP
fibroblast	fibroblast	NN	I-NP
primary	primary	JJ	I-NP
chicken	chicken	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
]	]	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
primary	primary	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
were	were	VBD	0
isolated	isolated	VBN	0
from	from	IN	0
10-day-old	10-day-old	CD	0
chicken	chicken	NN	0
embryos	embryos	NNS	0
and	and	CC	0
cultured	cultured	NN	0
for	for	IN	0
4	4	CD	0
days	days	NNS	0
.	.	.	0
These	These	DT	0
cultures	cultures	NNS	0
were	were	VBD	0
passaged	passaged	VBN	0
once	once	RB	0
and	and	CC	0
used	used	VBN	0
as	as	IN	0
secondary	secondary	JJ	B-NP
culture	culture	NN	I-NP
at	at	IN	0
a	a	DT	0
density	density	NN	0
of	of	IN	0
0.3	0.3	CD	0
×	×	CD	0
106	106	CD	0
cells	cells	CD	0
/	/	CD	0
35	35	CD	0
mm	mm	JJ	0
plate	plate	NN	0
.	.	.	0
Due	Due	JJ	0
to	to	TO	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
primary	primary	JJ	B-NP
cell	cell	NN	I-NP
rather	rather	RB	0
than	than	IN	0
cell	cell	NN	0
lines	lines	NNS	0
,	,	,	0
there	there	EX	0
are	are	VBP	0
variations	variations	NNS	0
in	in	IN	0
cellular	cellular	JJ	B-NP
response	response	NN	I-NP
between	between	IN	0
sets	sets	NNS	0
of	of	IN	0
cells	cells	NNS	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
internal	internal	JJ	B-NP
control	control	NN	I-NP
were	were	VBD	0
always	always	RB	0
included	included	VBN	0
and	and	CC	0
results	results	NNS	0
from	from	IN	0
different	different	JJ	0
batches	batches	NNS	0
of	of	IN	0
cells	cells	NNS	0
were	were	VBD	0
not	not	RB	0
averaged	averaged	VBD	0
.	.	.	0
secondary	secondary	JJ	B-NP
culture	culture	NN	I-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
750	750	CD	0
ng	ng	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
cCAF	cCAF	NN	I-NP
[	[	-LRB-	0
68	68	CD	0
nM	nM	NN	B-NP
]	]	-RRB-	0
or	or	CC	0
its	its	PRP$	0
terminal	terminal	NN	B-NP
peptide	peptide	NN	I-NP
in	in	IN	0
199	199	CD	0
/	/	CD	0
tryptose	tryptose	CD	B-NP
phosphate	phosphate	CD	I-NP
broth	broth	NN	I-NP
and	and	CC	0
2	2	CD	0
%	%	NN	0
donor	donor	NN	B-NP
calf	calf	NN	I-NP
serum	serum	NN	I-NP
.	.	.	0
This	This	DT	0
dose	dose	NN	0
of	of	IN	0
cCAF	cCAF	NNP	B-NP
was	was	VBD	0
chosen	chosen	VBN	0
because	because	IN	0
it	it	PRP	0
was	was	VBD	0
the	the	DT	0
optimal	optimal	JJ	B-NP
dose	dose	NN	I-NP
for	for	IN	0
inducing	inducing	JJ	0
myofibroblast	myofibroblast	NN	B-NP
differentiation	differentiation	NN	I-NP
,	,	,	0
cells	cells	NNS	0
known	known	VBN	0
to	to	TO	0
produce	produce	VB	0
large	large	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
extracellular	extracellular	NN	B-NP
matrix	matrix	NN	I-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
Media	Media	NNS	0
was	was	VBD	0
changed	changed	VBN	0
and	and	CC	0
new	new	JJ	0
cCAF	cCAF	JJ	0
or	or	CC	0
peptide	peptide	NN	B-NP
added	added	VBD	0
every	every	DT	0
day	day	NN	0
for	for	IN	0
4	4	CD	0
days	days	NNS	0
.	.	.	0
immunoblotting	immunoblotting	NN	B-NP
protein	protein	NN	I-NP
were	were	VBD	0
extracted	extracted	VBN	0
from	from	IN	0
the	the	DT	0
cells	cells	NNS	0
after	after	IN	0
4	4	CD	0
days	days	NNS	0
of	of	IN	0
treatment	treatment	NN	0
,	,	,	0
using	using	VBG	0
150	150	CD	0
containing	containing	VBG	B-NP
protease	protease	NN	I-NP
inhibitor	inhibitor	NN	I-NP
mm	mm	NN	I-NP
ripa	ripa	NNP	I-NP
buffer	buffer	NN	I-NP
.	.	.	0
protein	protein	NN	B-NP
concentration	concentration	NN	I-NP
were	were	VBD	0
determined	determined	VBN	0
using	using	VBG	0
the	the	DT	0
DC	DC	NN	B-NP
protein	protein	NN	I-NP
assay	assay	NN	I-NP
kit	kit	NN	I-NP
(	(	-LRB-	0
Bio-Rad	Bio-Rad	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
samples	samples	NNS	0
were	were	VBD	0
adjusted	adjusted	VBN	0
to	to	TO	0
contain	contain	VB	0
equal	equal	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
protein	protein	NN	B-NP
.	.	.	0
Proteins	Proteins	NNS	0
were	were	VBD	0
separated	separated	VBN	0
on	on	IN	0
7.5	7.5	CD	0
%	%	NN	0
Doucet	Doucet	FW	0
gels	gels	FW	0
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
and	and	CC	0
transferred	transferred	VBN	0
to	to	TO	0
nitrocellulosa	nitrocellulosa	NN	B-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
a	a	DT	0
wet-transfer	wet-transfer	JJ	B-NP
apparatus	apparatus	NN	I-NP
(	(	-LRB-	0
Bio-Rad	Bio-Rad	NNP	B-NP
)	)	-RRB-	0
at	at	IN	0
100	100	CD	0
V	V	NNP	0
for	for	IN	0
45	45	CD	0
min	min	NN	B-NP
.	.	.	0
The	The	DT	0
membranes	membranes	NN	0
were	were	VBD	0
blocked	blocked	VBN	0
for	for	IN	0
1	1	CD	0
h	h	NN	0
in	in	IN	0
5	5	CD	0
%	%	NN	0
milk	milk	NN	0
in	in	IN	0
ttb	ttb	NN	B-NP
and	and	CC	0
then	then	RB	0
incubated	incubated	JJ	0
overnight	overnight	JJ	0
at	at	IN	0
4°C	4°C	CD	0
in	in	IN	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
50	50	CD	0
anti-Coll	anti-Coll	JJ	B-NP
I	I	NN	I-NP
,	,	,	0
anti-Coll	anti-Coll	NNP	B-NP
III	III	NNP	I-NP
and	and	CC	0
anti-FN	anti-FN	JJ	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
100	100	CD	0
TIMP-1	TIMP-1	CD	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
500	500	CD	0
anti-MMP-1	anti-MMP-1	CD	B-NP
and	and	CC	0
anti-TIMP-2	anti-TIMP-2	NNP	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
anti-TN	anti-TN	NN	B-NP
)	)	-RRB-	0
,	,	,	0
in	in	IN	0
1	1	CD	0
%	%	NN	0
milk	milk	NN	0
in	in	IN	0
ttb	ttb	NN	B-NP
.	.	.	0
The	The	DT	0
membranes	membranes	NN	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
for	for	IN	0
10	10	CD	0
min	min	CD	B-NP
each	each	DT	0
with	with	IN	0
ttb	ttb	NN	B-NP
,	,	,	0
incubated	incubated	VBG	0
in	in	IN	0
anti-mouse	anti-mouse	JJ	B-NP
or	or	CC	0
anti-rabbit	anti-rabbit	NNP	B-NP
HRP	HRP	NNP	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
10,000	10,000	CD	0
)	)	-RRB-	0
in	in	IN	0
1	1	CD	0
%	%	NN	0
milk	milk	NN	0
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
and	and	CC	0
washed	washed	VBN	0
as	as	IN	0
above	above	JJ	0
,	,	,	0
the	the	DT	0
bands	bands	NNS	0
visualized	visualized	VBP	0
using	using	VBG	0
the	the	DT	0
enhanced	enhanced	VBN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
chemiluminescence	chemiluminescence	NN	I-NP
(	(	-LRB-	0
Amersham	Amersham	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Densitometry	Densitometry	NNP	0
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
BandScan	BandScan	JJ	0
software	software	NN	0
(	(	-LRB-	0
Glyko	Glyko	NNP	0
)	)	-RRB-	0
.	.	.	0
Immunostaining	Immunostaining	NNP	B-NP
At	At	IN	0
the	the	DT	0
end	end	NN	0
of	of	IN	0
treatment	treatment	NN	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
rinsed	rinsed	VBN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
fixed	fixed	VBN	B-NP
and	and	CC	0
permeabilized	permeabilized	NN	0
in	in	IN	0
4	4	CD	0
%	%	NN	0
paraformaldehyde	paraformaldehyde	NN	B-NP
with	with	IN	0
0.15	0.15	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
.	.	.	0
After	After	IN	0
fixation	fixation	NN	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
and	and	CC	0
then	then	RB	0
incubated	incubated	VBN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
containing	containing	VBG	0
0.1	0.1	CD	0
M	M	NNP	0
glycine	glycine	NN	B-NP
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
blocked	blocked	VBN	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
with	with	IN	0
10	10	CD	0
%	%	NN	0
goat	goat	NN	B-NP
serum	serum	NN	I-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
incubated	incubated	VBG	0
with	with	IN	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
100	100	CD	0
)	)	-RRB-	0
in	in	IN	0
1	1	CD	0
%	%	NN	0
bsa/pb	bsa/pb	NN	B-NP
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
at	at	IN	0
room	room	NN	B-NP
temperature	temperature	NN	I-NP
(	(	-LRB-	0
RT	RT	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
washed	washed	VBD	0
three	three	CD	0
times	times	NNS	0
with	with	IN	0
0.1	0.1	CD	0
%	%	NN	0
bsa/pb	bsa/pb	NN	B-NP
for	for	IN	0
10	10	CD	0
min	min	CD	B-NP
each	each	DT	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
in	in	IN	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
in	in	IN	0
1	1	CD	0
%	%	NN	0
bsa/pb	bsa/pb	NN	B-NP
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
at	at	IN	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
,	,	,	0
washed	washed	VBD	0
three	three	CD	0
times	times	NNS	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
with	with	IN	0
0.1	0.1	CD	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
albumin	albumin	NN	I-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
and	and	CC	0
mounted	mounted	VBN	0
with	with	IN	0
Vectashield	Vectashield	NNP	B-NP
.	.	.	0
Zymography	Zymography	NNP	B-NP
Zymography	Zymography	NNP	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
denaturing	denaturing	JJ	B-NP
polyacrylamida	polyacrylamida	NN	I-NP
gels	gels	VBP	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
protocol	protocol	NN	0
of	of	IN	0
ref.	ref.	NNP	B-NP
[	[	-LRB-	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
Gels	Gels	JJ	0
to	to	TO	0
test	test	VB	0
for	for	IN	0
gelatinolytic	gelatinolytic	JJ	B-NP
activity	activity	NN	I-NP
contained	contained	VBD	0
1	1	CD	0
%	%	NN	0
gelatin	gelatin	NN	B-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
those	those	DT	0
that	that	WDT	0
tested	tested	VBD	0
for	for	IN	0
caseinolytic	caseinolytic	JJ	B-NP
activity	activity	NN	I-NP
had	had	VBD	0
1	1	CD	0
%	%	NN	0
casein	casein	NN	B-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
5	5	CD	0
μl	μl	NN	B-NP
of	of	IN	0
0.25	0.25	CD	0
%	%	NN	0
trypsin-EDTA	trypsin-EDTA	NN	B-NP
(	(	-LRB-	0
Gibco-BRL	Gibco-BRL	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
a	a	DT	0
casein	casein	JJ	B-NP
zymogram	zymogram	NN	I-NP
positive	positive	JJ	I-NP
control	control	NN	I-NP
.	.	.	0
Plasminogen	Plasminogen	JJ	B-NP
activity	activity	NN	I-NP
assay	assay	VBD	0
A	A	DT	0
chromogenic	chromogenic	NN	B-NP
plasminogen	plasminogen	NN	I-NP
activator	activator	NN	I-NP
substrate	substrate	NN	I-NP
(	(	-LRB-	0
Boc-Val-Gly-Arg-βNA.AcOH	Boc-Val-Gly-Arg-βNA.AcOH	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Calbiochem.	Calbiochem.	CD	B-NP
50	50	CD	0
μl	μl	NN	B-NP
of	of	IN	0
a	a	DT	0
10	10	CD	0
mM	mM	JJ	B-NP
stock	stock	NN	I-NP
solution	solution	NN	I-NP
of	of	IN	0
substrate	substrate	NN	0
in	in	IN	0
water	water	NN	0
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
200	200	CD	0
μl	μl	CD	B-NP
0.1	0.1	CD	0
buffer	buffer	NN	B-NP
ph	ph	NN	I-NP
mm	mm	NN	I-NP
hepe	hepe	NN	I-NP
8.0	8.0	FW	0
and	and	CC	0
heated	heated	VBN	0
to	to	TO	0
25°C.	25°C.	CD	0
25	25	CD	0
μl	μl	CD	B-NP
fibroblast	fibroblast	CD	I-NP
substrate	substrate	NN	I-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
the	the	DT	0
substrate	substrate	NN	0
and	and	CC	0
incubated	incubated	NN	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
.	.	.	0
Absorbance	Absorbance	NNP	B-NP
was	was	VBD	0
then	then	RB	0
read	read	VBN	0
at	at	IN	0
405	405	CD	0
nm	nm	NN	B-NP
.	.	.	0
Positive	Positive	JJ	B-NP
control	control	NN	I-NP
:	:	:	0
Supernatant	Supernatant	NNP	B-NP
from	from	IN	0
Rous	Rous	NNP	B-NP
sarcoma	sarcoma	NN	I-NP
virus-transformed	virus-transformed	FW	0
cef	cef	NN	B-NP
(	(	-LRB-	0
tcef	tcef	NN	B-NP
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
produce	produce	VB	0
high	high	JJ	0
levels	levels	NNS	0
of	of	IN	0
PA	PA	NNP	0
.	.	.	0
Inhibition	Inhibition	NNP	0
of	of	IN	0
TN	TN	NNP	B-NP
expression	expression	NN	I-NP
For	For	IN	0
these	these	DT	0
experiments	experiments	NNS	0
we	we	PRP	0
used	used	VBD	0
phosphothioated	phosphothioated	FW	0
antisense	antisense	NN	B-NP
oligodeoxynucleotide	oligodeoxynucleotide	NN	I-NP
(	(	-LRB-	0
ODN	ODN	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
synthesized	synthesized	NN	0
and	and	CC	0
HPLC	HPLC	NNP	B-NP
purified	purified	NN	I-NP
by	by	IN	0
sigma	sigma	NN	B-NP
genosy	genosy	NN	I-NP
,	,	,	0
to	to	TO	0
block	block	VB	0
the	the	DT	0
TN	TN	NNP	B-NP
production	production	NN	I-NP
.	.	.	0
The	The	DT	0
sequences	sequences	NN	0
for	for	IN	0
the	the	DT	0
oligonucleotide	oligonucleotide	NN	B-NP
were	were	VBD	0
the	the	DT	0
same	same	JJ	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
50	50	CD	0
]	]	-RRB-	0
except	except	IN	0
that	that	WDT	0
we	we	PRP	0
used	used	VBD	0
phosphothioated	phosphothioated	JJ	B-NP
oligo	oligo	NN	I-NP
rather	rather	RB	0
than	than	IN	0
morpholino	morpholino	JJ	B-NP
oligo	oligo	NN	I-NP
.	.	.	0
The	The	DT	0
oligodeoxynucleotide	oligodeoxynucleotide	NN	B-NP
antisense	antisense	JJ	I-NP
sequence	sequence	NN	I-NP
was	was	VBD	0
5	5	CD	0
'	'	POS	B-NP
-GGAGTCCCATTGTAGTGCTCAGTTC-3	-GGAGTCCCATTGTAGTGCTCAGTTC-3	NNP	I-NP
'	'	POS	0
.	.	.	0
The	The	DT	0
sense	sense	NN	B-NP
strand	strand	NN	I-NP
of	of	IN	0
this	this	DT	0
oligodeoxynucleotide	oligodeoxynucleotide	NN	B-NP
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
control	control	NN	0
(	(	-LRB-	0
5	5	CD	0
'	'	POS	B-NP
-GAACTGAGCACTACAATGGGACTCC-3	-GAACTGAGCACTACAATGGGACTCC-3	NNP	I-NP
'	'	POS	0
)	)	-RRB-	0
.	.	.	0
When	When	WRB	0
preparing	preparing	VBG	0
the	the	DT	0
cell	cell	NN	0
cultures	cultures	NNS	0
,	,	,	0
1	1	CD	0
μM	μM	JJ	0
and	and	CC	0
2	2	CD	0
antisense	antisense	NN	B-NP
μm	μm	NN	I-NP
or	or	CC	0
sense	sense	NN	B-NP
ODN	ODN	NNP	I-NP
were	were	VBD	0
added	added	VBN	0
to	to	TO	0
the	the	DT	0
cells	cells	NNS	0
at	at	IN	0
plating	plating	NN	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
where	where	WRB	0
treated	treated	VBN	0
with	with	IN	0
antisense	antisense	NN	B-NP
or	or	CC	0
sense	sense	NN	B-NP
ODN	ODN	NNP	I-NP
and	and	CC	0
cCAF	cCAF	JJ	0
every	every	DT	0
24	24	CD	0
hr	hr	NN	B-NP
for	for	IN	0
3	3	CD	0
days	days	NNS	0
to	to	TO	0
allow	allow	VB	0
ecm	ecm	NN	B-NP
molecule	molecule	NN	I-NP
accumulation	accumulation	NN	I-NP
.	.	.	0
total	total	JJ	B-NP
rna	rna	NN	I-NP
northern	northern	JJ	I-NP
was	was	VBD	0
extracted	extracted	VBN	0
using	using	VBG	0
TRIzol	TRIzol	JJ	B-NP
reagent	reagent	NN	I-NP
from	from	IN	0
untreated	untreated	JJ	0
fibroblast	fibroblast	NN	B-NP
and	and	CC	0
fibroblasts	fibroblasts	VB	0
treated	treated	VBN	0
with	with	IN	0
750	750	CD	0
ng	ng	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
cCAF	cCAF	NN	I-NP
for	for	IN	0
4-48	4-48	CD	0
hr	hr	NN	B-NP
.	.	.	0
Transfer	Transfer	NN	0
of	of	IN	0
rrnas,	rrnas,	NN	B-NP
to	to	TO	0
membrane	membrane	NNS	0
was	was	VBD	0
performed	performed	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
rna	rna	NN	B-NP
probe	probe	NN	I-NP
were	were	VBD	0
made	made	VBN	0
using	using	VBG	0
the	the	DT	0
Strip-EZ	Strip-EZ	JJ	B-NP
kit	kit	NN	I-NP
from	from	IN	0
Ambion	Ambion	NNP	B-NP
(	(	-LRB-	0
Arlington	Arlington	NNP	0
,	,	,	0
TX	TX	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Membranes	Membranes	NNP	0
were	were	VBD	0
prehybridized	prehybridized	VBN	0
for	for	IN	0
2	2	CD	0
hr	hr	NN	B-NP
in	in	IN	0
Ambion	Ambion	NNP	B-NP
Hybridization	Hybridization	NNP	I-NP
buffer	buffer	NN	I-NP
at	at	IN	0
62°C	62°C	NNP	0
,	,	,	0
and	and	CC	0
hybridized	hybridized	JJ	0
O	O	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
at	at	IN	0
62°C	62°C	CD	0
.	.	.	0
Membranes	Membranes	NNP	0
were	were	VBD	0
washed	washed	VBN	0
with	with	IN	0
2	2	CD	0
×	×	CD	0
SSC	SSC	CD	0
/	/	CD	0
0.1	0.1	CD	0
%	%	NN	0
SDS	SDS	NN	0
at	at	IN	0
62°C	62°C	NNP	0
and	and	CC	0
exposed	exposed	VBN	0
to	to	TO	0
film	film	NN	0
for	for	IN	0
6-48	6-48	CD	0
hrs	hrs	NNS	0
.	.	.	0
RT-PCR	RT-PCR	NNP	B-NP
Total	Total	NNP	I-NP
RNA	RNA	NNP	I-NP
was	was	VBD	0
extracted	extracted	VBN	0
as	as	IN	0
above	above	JJ	0
.	.	.	0
real	real	JJ	B-NP
time	time	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
polymerase	polymerase	NN	I-NP
chain	chain	NN	I-NP
reaction	reaction	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
the	the	DT	0
Promega	Promega	NNP	B-NP
Access	Access	NNP	I-NP
RT-PCR	RT-PCR	NNP	I-NP
System	System	NNP	I-NP
,	,	,	0
following	following	VBG	0
Promega	Promega	NNP	0
's	's	POS	0
instruction	instruction	NN	B-NP
.	.	.	0
The	The	DT	0
first	first	JJ	0
strand	strand	NN	0
was	was	VBD	0
synthesized	synthesized	VBN	0
at	at	IN	0
48°C	48°C	NNP	0
and	and	CC	0
DNA	DNA	NNP	B-NP
was	was	VBD	0
amplified	amplified	VBN	0
at	at	IN	0
95°C	95°C	CD	0
45	45	CD	0
sec	sec	NN	0
,	,	,	0
55°C	55°C	CD	0
1	1	CD	0
min	min	NN	B-NP
,	,	,	0
68°C	68°C	CD	0
1.5	1.5	CD	0
min	min	NN	B-NP
for	for	IN	0
40	40	CD	0
cycles.	cycles.	CD	0
3	3	CD	0
μl	μl	JJ	B-NP
Quantum	Quantum	NNP	I-NP
mRNA	mRNA	JJ	0
classic	classic	JJ	0
18S	18S	CD	0
primers	primers	NN	0
from	from	IN	0
Ambion	Ambion	NNP	B-NP
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
quantify	quantify	VB	0
total	total	JJ	B-NP
rna	rna	NN	I-NP
level	level	JJ	I-NP
.	.	.	0
Primers	Primers	RB	0
used	used	VBN	0
for	for	IN	0
TN	TN	NNP	B-NP
amplification	amplification	NN	I-NP
:	:	:	0
sense	sense	NN	0
5	5	CD	B-NP
'	'	POS	I-NP
AAATGCATCTGCGAGGGC	AAATGCATCTGCGAGGGC	NNP	I-NP
,	,	,	0
antisense	antisense	CD	B-NP
5	5	CD	0
"GGAAGCTTGTTATTGCAGTCCTTCGG	"GGAAGCTTGTTATTGCAGTCCTTCGG	CD	0
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
wounding	wounding	VBG	B-NP
experiment	experiment	NN	I-NP
full-thickness	full-thickness	NN	I-NP
excision	excision	NN	I-NP
wound	wound	NN	I-NP
(	(	-LRB-	0
approximately	approximately	RB	0
0.5	0.5	CD	0
×	×	CD	0
0.5	0.5	CD	0
cm	cm	CD	0
)	)	-RRB-	0
were	were	VBD	0
made	made	VBN	0
on	on	IN	0
the	the	DT	0
underside	underside	NN	0
of	of	IN	0
the	the	DT	0
wings	wings	NNS	0
of	of	IN	0
2	2	CD	0
week-old	week-old	JJ	B-NP
chick	chick	NN	I-NP
,	,	,	0
using	using	VBG	0
a	a	DT	0
scalpel	scalpel	JJ	0
blade	blade	NN	0
.	.	.	0
The	The	DT	0
left	left	JJ	0
wing	wing	NN	0
was	was	VBD	0
treated	treated	VBN	0
with	with	IN	0
vehicle	vehicle	NN	B-NP
alone	alone	RB	0
,	,	,	0
and	and	CC	0
the	the	DT	0
right	right	JJ	0
wing	wing	NN	0
with	with	IN	0
1	1	CD	0
μg	μg	JJ	B-NP
cCAF	cCAF	NN	I-NP
.	.	.	0
The	The	DT	0
wounds	wounds	NNS	0
were	were	VBD	0
photographed	photographed	VBN	0
immediately	immediately	RB	0
after	after	IN	0
wounding	wounding	NN	0
and	and	CC	0
then	then	RB	0
covered	covered	VBN	0
with	with	IN	0
Biocclusive	Biocclusive	NNP	B-NP
bandage.	bandage.	CD	I-NP
50	50	CD	0
μl	μl	JJ	B-NP
vehicle	vehicle	NN	I-NP
or	or	CC	0
cCAF	cCAF	NNP	B-NP
were	were	VBD	0
deposited	deposited	VBN	0
through	through	IN	0
the	the	DT	0
bandage	bandage	NN	0
onto	onto	IN	0
the	the	DT	0
wound	wound	NN	0
using	using	VBG	0
a	a	DT	0
30-gauge	30-gauge	JJ	0
needle	needle	NN	0
.	.	.	0
This	This	DT	0
procedure	procedure	NN	0
was	was	VBD	0
repeated	repeated	VBN	0
the	the	DT	0
next	next	JJ	0
day	day	NN	0
and	and	CC	0
every	every	DT	0
other	other	JJ	0
day	day	NN	0
thereafter	thereafter	RB	0
on	on	IN	0
days	days	NNS	0
3	3	CD	0
,	,	,	0
5	5	CD	0
and	and	CC	0
7	7	CD	0
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
collected	collected	VBN	0
at	at	IN	0
days	days	NNS	0
3	3	CD	0
and	and	CC	0
7	7	CD	0
post-wounding	post-wounding	NN	0
for	for	IN	0
ECM	ECM	NNP	B-NP
analysis	analysis	NN	I-NP
.	.	.	0
All	All	DT	0
experimental	experimental	JJ	B-NP
work	work	NN	I-NP
with	with	IN	0
animals	animals	NNS	0
reported	reported	VBD	0
here	here	RB	0
was	was	VBD	0
done	done	VBN	0
under	under	IN	0
full	full	JJ	0
compliance	compliance	NN	0
with	with	IN	0
our	our	PRP$	0
animal	animal	JJ	0
protocol	protocol	NN	0
approved	approved	VBN	0
by	by	IN	0
appropriate	appropriate	JJ	0
campus	campus	NN	0
authorities	authorities	NNS	0
.	.	.	0
Preparation	Preparation	NN	B-NP
and	and	CC	0
staining	staining	NN	0
of	of	IN	0
wing	wing	JJ	0
sections	sections	NNS	0
At	At	IN	0
the	the	DT	0
specified	specified	JJ	0
time	time	NN	B-NP
point	point	NN	I-NP
,	,	,	0
chickens	chickens	NNS	0
were	were	VBD	0
euthanized	euthanized	VBN	0
with	with	IN	0
sodium	sodium	JJ	B-NP
pentobarbitol	pentobarbitol	NN	I-NP
.	.	.	0
The	The	DT	0
wounded	wounded	JJ	0
wings	wings	NNS	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
fixed	fixed	VBN	B-NP
for	for	IN	0
18	18	CD	0
hr	hr	NN	B-NP
in	in	IN	0
4	4	CD	0
%	%	NN	0
paraformaldehyda	paraformaldehyda	NN	B-NP
and	and	CC	0
decalcified	decalcified	NN	B-NP
for	for	IN	0
3	3	CD	0
days	days	NNS	0
in	in	IN	0
5	5	CD	0
%	%	NN	0
formic	formic	NN	B-NP
acid	acid	NN	I-NP
,	,	,	0
2.5	2.5	CD	0
%	%	NN	0
formaldehyde	formaldehyde	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
The	The	DT	0
tissue	tissue	NN	0
was	was	VBD	0
embedded	embedded	VBN	0
in	in	IN	0
paraffin	paraffin	NN	B-NP
and	and	CC	0
sectioned	sectioned	NN	0
.	.	.	0
Sections	Sections	NNS	0
were	were	VBD	0
stained	stained	VBN	0
with	with	IN	0
Masson	Masson	NNP	B-NP
Trichrome	Trichrome	NNP	I-NP
to	to	TO	0
visualize	visualize	VB	0
interstitial	interstitial	JJ	B-NP
collagen	collagen	NN	I-NP
.	.	.	0
Other	Other	JJ	0
sections	sections	NNS	0
were	were	VBD	0
immunolabeled	immunolabeled	VBN	0
for	for	IN	0
fibronectin	fibronectin	NN	B-NP
or	or	CC	0
tenascin	tenascin	NN	B-NP
.	.	.	0
Sections	Sections	NNS	0
were	were	VBD	0
deparaffinized	deparaffinized	VBN	0
in	in	IN	0
3	3	CD	0
changes	changes	NNS	0
of	of	IN	0
Hemo-De	Hemo-De	JJ	B-NP
for	for	IN	0
15	15	CD	0
min	min	CD	B-NP
each	each	DT	0
and	and	CC	0
rehydrated	rehydrated	NN	0
in	in	IN	0
a	a	DT	0
descending	descending	JJ	0
ethanol	ethanol	JJ	B-NP
series	series	NN	I-NP
(	(	-LRB-	0
5	5	CD	0
min	min	CD	B-NP
each	each	DT	0
:	:	:	0
100	100	CD	0
%	%	NN	0
,	,	,	0
95	95	CD	0
%	%	NN	0
,	,	,	0
70	70	CD	0
%	%	NN	0
,	,	,	0
50	50	CD	0
%	%	NN	0
,	,	,	0
30	30	CD	0
%	%	NN	0
ethanol	ethanol	NN	B-NP
)	)	-RRB-	0
.	.	.	0
After	After	IN	0
rinsing	rinsing	NN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
sections	sections	NNS	0
were	were	VBD	0
fixed	fixed	VBN	B-NP
in	in	IN	0
2	2	CD	0
%	%	NN	0
paraformaldehyde	paraformaldehyde	NN	B-NP
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
.	.	.	0
Autofluorescence	Autofluorescence	NNP	B-NP
and	and	CC	0
non-specific	non-specific	JJ	B-NP
staining	staining	NN	I-NP
were	were	VBD	0
blocked	blocked	VBN	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
in	in	IN	0
0.1	0.1	CD	0
M	M	NNP	0
glycine	glycine	NN	B-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
30	30	CD	0
min	min	NN	B-NP
in	in	IN	0
1	1	CD	0
%	%	NN	0
Evans	Evans	NNP	0
Blue	Blue	NNP	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
to	to	TO	0
quench	quench	VB	0
red	red	JJ	0
blood	blood	NN	B-NP
cell	cell	NN	I-NP
autofluorescence	autofluorescence	NN	I-NP
.	.	.	0
Sections	Sections	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
anti-FN	anti-FN	JJ	B-NP
or	or	CC	0
anti-tn	anti-tn	NN	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
50	50	CD	0
)	)	-RRB-	0
in	in	IN	0
1	1	CD	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
albumin	albumin	NN	I-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
for	for	IN	0
2	2	CD	0
hr	hr	NN	B-NP
at	at	IN	0
room	room	NN	B-NP
temperature	temperature	NN	I-NP
.	.	.	0
After	After	IN	0
3	3	CD	0
×	×	CD	0
10	10	CD	0
min	min	JJ	B-NP
wash	wash	NN	I-NP
in	in	IN	0
0.1	0.1	CD	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
albumin	albumin	NN	I-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
the	the	DT	0
sections	sections	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
for	for	IN	0
40	40	CD	0
min	min	NN	B-NP
with	with	IN	0
anti-mouse	anti-mouse	NNP	B-NP
Alexa	Alexa	NNP	I-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
:	:	:	0
200	200	CD	0
)	)	-RRB-	0
in	in	IN	0
1	1	CD	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
albumin	albumin	NN	I-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
.	.	.	0
They	They	PRP	0
were	were	VBD	0
then	then	RB	0
washed	washed	VBN	0
and	and	CC	0
mounted	mounted	VBN	0
with	with	IN	0
Vectashield	Vectashield	NNP	B-NP
.	.	.	0
protein	protein	NN	B-NP
extract	extract	NN	I-NP
of	of	IN	0
wounds	wounds	JJ	0
wound	wound	NN	B-NP
tissue	tissue	NN	I-NP
were	were	VBD	0
immediately	immediately	RB	0
frozen	frozen	VBN	0
on	on	IN	0
dry	dry	JJ	0
ice	ice	NN	0
and	and	CC	0
stored	stored	VBD	0
at	at	IN	0
-70°C	-70°C	CD	0
.	.	.	0
To	To	TO	0
extract	extract	VB	0
protein	protein	NN	B-NP
,	,	,	0
the	the	DT	0
tissue	tissue	NN	0
was	was	VBD	0
ground	ground	NN	0
with	with	IN	0
glass	glass	NN	0
beads	beads	NN	0
in	in	IN	0
a	a	DT	0
mortar	mortar	NN	0
and	and	CC	0
pestle	pestle	NN	0
on	on	IN	0
dry	dry	JJ	0
ice	ice	NN	0
.	.	.	0
The	The	DT	0
powdered	powdered	JJ	0
tissue	tissue	NN	0
was	was	VBD	0
dissolved	dissolved	VBN	0
in	in	IN	0
RIPA	RIPA	NNP	B-NP
containing	containing	VBG	0
300	300	CD	0
mM	mM	JJ	B-NP
salt	salt	NN	I-NP
and	and	CC	0
a	a	DT	0
cocktail	cocktail	NN	0
of	of	IN	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
,	,	,	0
and	and	CC	0
vortexed	vortexed	JJ	0
vigorously	vigorously	NN	0
.	.	.	0
After	After	IN	0
centrifugation	centrifugation	NN	B-NP
,	,	,	0
the	the	DT	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
used	used	VBN	0
in	in	IN	0
immunoblot	immunoblot	NN	B-NP
.	.	.	0
Transwell	Transwell	JJ	B-NP
assay	assay	NN	I-NP
for	for	IN	0
migration	migration	CD	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
6cells	6cells	CD	0
in	in	IN	0
100	100	CD	0
μl	μl	CD	B-NP
199	199	CD	0
medium	medium	NN	0
containing	containing	VBG	0
2	2	CD	0
%	%	NN	0
serum	serum	NN	B-NP
were	were	VBD	0
plated	plated	VBN	0
on	on	IN	0
the	the	DT	0
underside	underside	NN	0
of	of	IN	0
transwell	transwell	JJ	B-NP
membrane	membrane	NN	I-NP
by	by	IN	0
inverting	inverting	VBG	0
the	the	DT	0
insert	insert	NN	0
.	.	.	0
They	They	PRP	0
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
adhere	adhere	VB	0
for	for	IN	0
30	30	CD	0
minutes	minutes	NNS	0
,	,	,	0
then	then	RB	0
the	the	DT	0
well	well	RB	0
was	was	VBD	0
turned	turned	VBN	0
right	right	JJ	0
side	side	NN	0
up	up	RB	0
and	and	CC	0
both	both	DT	0
sides	sides	NNS	0
of	of	IN	0
the	the	DT	0
well	well	RB	0
were	were	VBD	0
filled	filled	VBN	0
with	with	IN	0
serum-containing	serum-containing	JJ	0
medium	medium	NN	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
recover	recover	VB	0
for	for	IN	0
24	24	CD	0
hr	hr	NN	B-NP
,	,	,	0
and	and	CC	0
express	express	VB	0
the	the	DT	0
ccaf	ccaf	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
Then	Then	RB	0
the	the	DT	0
medium	medium	NN	0
in	in	IN	0
the	the	DT	0
top	top	NN	0
well	well	RB	0
was	was	VBD	0
changed	changed	VBN	0
to	to	TO	0
serum-free	serum-free	NN	B-NP
medium	medium	JJ	I-NP
containing	containing	FW	0
50-1000	50-1000	FW	0
ng	ng	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
cCAF	cCAF	NN	I-NP
or	or	CC	0
2	2	CD	0
%	%	NN	0
serum	serum	NN	B-NP
(	(	-LRB-	0
positive	positive	JJ	B-NP
control	control	NN	I-NP
)	)	-RRB-	0
;	;	:	0
serum	serum	JJ	B-NP
free	free	JJ	0
medium	medium	NN	0
alone	alone	RB	0
was	was	VBD	0
placed	placed	VBN	0
in	in	IN	0
the	the	DT	0
bottom	bottom	NN	0
well	well	RB	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
migrate	migrate	VB	0
towards	towards	IN	0
the	the	DT	0
chemoattractant	chemoattractant	NN	B-NP
for	for	IN	0
24	24	CD	0
hr	hr	NN	B-NP
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
on	on	IN	0
the	the	DT	0
underside	underside	NN	0
of	of	IN	0
the	the	DT	0
membrane	membrane	NN	0
were	were	VBD	0
removed	removed	VBN	0
with	with	IN	0
a	a	DT	0
cotton	cotton	NN	0
swab	swab	NN	0
.	.	.	0
The	The	DT	0
membranes	membranes	NN	0
were	were	VBD	0
then	then	RB	0
fixed	fixed	VBN	B-NP
and	and	CC	0
stained	stained	NN	0
with	with	IN	0
2	2	CD	0
%	%	NN	0
toludine	toludine	NN	B-NP
blue	blue	NN	I-NP
in	in	IN	0
formaldehyde	formaldehyde	NN	B-NP
.	.	.	0
To	To	TO	0
determine	determine	VB	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
migrated	migrated	JJ	0
cells	cells	NNS	0
,	,	,	0
all	all	DT	0
cells	cells	NNS	0
on	on	IN	0
the	the	DT	0
upper	upper	JJ	0
side	side	NN	0
of	of	IN	0
the	the	DT	0
membrane	membrane	NN	0
were	were	VBD	0
counted	counted	VBN	0
.	.	.	0
Control	Control	NN	0
for	for	IN	0
chemotaxi	chemotaxi	NN	B-NP
was	was	VBD	0
performed	performed	VBN	0
by	by	IN	0
adding	adding	VBG	0
1000	1000	CD	0
ng	ng	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
cCAF	cCAF	JJ	I-NP
to	to	TO	0
both	both	DT	0
wells	wells	NNS	0
of	of	IN	0
the	the	DT	0
Transwell	Transwell	JJ	B-NP
unit	unit	NN	I-NP
.	.	.	0
Cloning	Cloning	NN	B-NP
ring	ring	VBP	0
assay	assay	VBN	0
for	for	IN	0
migration	migration	CD	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
6cells	6cells	CD	0
in	in	IN	0
100	100	CD	0
μl	μl	CD	B-NP
199	199	CD	0
medium	medium	NN	0
containing	containing	VBG	0
2	2	CD	0
%	%	NN	0
serum	serum	NN	B-NP
were	were	VBD	0
plated	plated	VBN	0
in	in	IN	0
a	a	DT	0
cloning	cloning	JJ	B-NP
ring	ring	NN	I-NP
in	in	IN	0
a	a	DT	0
35	35	CD	0
mm	mm	JJ	0
plate	plate	NN	0
.	.	.	0
They	They	PRP	0
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
adhere	adhere	VB	0
for	for	IN	0
1	1	CD	0
hour	hour	NN	0
,	,	,	0
then	then	RB	0
the	the	DT	0
ring	ring	NN	0
was	was	VBD	0
removed	removed	VBN	0
,	,	,	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
added	added	VBD	0
to	to	TO	0
the	the	DT	0
plate	plate	NN	0
and	and	CC	0
the	the	DT	0
cells	cells	NNS	0
photographed	photographed	VBN	0
on	on	IN	0
a	a	DT	0
phase-contrast	phase-contrast	JJ	B-NP
microscope	microscope	NN	I-NP
to	to	TO	0
record	record	VB	0
the	the	DT	0
area	area	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
and	and	CC	0
the	the	DT	0
edge	edge	NN	0
of	of	IN	0
the	the	DT	0
ring.	ring.	NNP	0
cCAF	cCAF	NNP	B-NP
was	was	VBD	0
then	then	RB	0
added	added	VBN	0
at	at	IN	0
various	various	JJ	0
doses	doses	NNS	0
(	(	-LRB-	0
0-1000	0-1000	FW	0
ng	ng	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
following	following	JJ	0
day	day	NN	0
the	the	DT	0
medium	medium	NN	0
was	was	VBD	0
changed	changed	VBN	0
and	and	CC	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
treated	treated	VBN	0
again	again	RB	0
.	.	.	0
On	On	IN	0
the	the	DT	0
third	third	JJ	0
day	day	NN	0
after	after	IN	0
plating	plating	NN	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
photographed	photographed	VBN	0
once	once	RB	0
more	more	JJR	0
before	before	IN	0
the	the	DT	0
experiment	experiment	NN	0
was	was	VBD	0
terminated	terminated	VBN	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
the	the	DT	0
extent	extent	NN	0
of	of	IN	0
cell	cell	NN	0
migration	migration	NN	0
,	,	,	0
we	we	PRP	0
measured	measured	VBD	0
the	the	DT	0
distance	distance	NN	0
between	between	IN	0
the	the	DT	0
edge	edge	NN	0
where	where	WRB	0
the	the	DT	0
cloning	cloning	JJ	B-NP
ring	ring	NN	I-NP
was	was	VBD	0
at	at	IN	0
day	day	NN	0
zero	zero	NN	0
and	and	CC	0
the	the	DT	0
edge	edge	NN	0
of	of	IN	0
the	the	DT	0
culture	culture	NN	0
delineated	delineated	NN	0
by	by	IN	0
the	the	DT	0
migrating	migrating	JJ	0
front	front	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
on	on	IN	0
the	the	DT	0
3	3	CD	0
rdday	rdday	NN	B-NP
.	.	.	0
In	In	IN	0
situhybridization	situhybridization	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
culture	culture	NN	I-NP
and	and	CC	0
probes	probes	NNS	0
were	were	VBD	0
prepared	prepared	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
(	(	-LRB-	0
Martins-Green	Martins-Green	NNP	B-NP
and	and	CC	0
Bissell	Bissell	NNP	0
,	,	,	0
1990	1990	CD	0
)	)	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
probes	probes	NNS	0
were	were	VBD	0
prepared	prepared	VBN	0
as	as	RB	0
follows	follows	VBZ	0
:	:	:	0
1	1	CD	0
pgem1	pgem1	NN	B-NP
μg	μg	NN	I-NP
/	/	NNP	0
cCAF	cCAF	NNP	B-NP
cDNA	cDNA	NNP	I-NP
was	was	VBD	0
transcribed	transcribed	VBN	0
for	for	IN	0
1	1	CD	0
1	1	CD	0
/	/	CD	0
2	2	CD	0
h	h	NN	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
a	a	DT	0
cocktail	cocktail	NN	0
containing	containing	VBG	0
100	100	CD	0
μM	μM	JJ	0
each	each	NN	0
of	of	IN	0
3H-ATP	3H-ATP	NNP	0
and	and	CC	0
3H-UTP	3H-UTP	NNP	0
(	(	-LRB-	0
Amersham	Amersham	NNP	B-NP
Corp.	Corp.	NNP	0
)	)	-RRB-	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
each	each	DT	0
GTP	GTP	NNP	B-NP
and	and	CC	0
CTP	CTP	NNP	B-NP
,	,	,	0
120	120	CD	0
mM	mM	JJ	B-NP
dithiothreitol	dithiothreitol	NN	I-NP
,	,	,	0
and	and	CC	0
100	100	CD	0
U	U	NNP	0
of	of	IN	0
T7	T7	CD	B-NP
polymerasa	polymerasa	NN	I-NP
(	(	-LRB-	0
Amersham	Amersham	NNP	B-NP
Corop.	Corop.	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
probe	probe	NN	0
was	was	VBD	0
separated	separated	VBN	0
from	from	IN	0
the	the	DT	0
free	free	JJ	0
nucleotide	nucleotide	NN	B-NP
in	in	IN	0
a	a	DT	0
Sephadex	Sephadex	NNP	B-NP
G-50	G-50	NNP	I-NP
column	column	NN	I-NP
equilibrated	equilibrated	NN	0
with	with	IN	0
50	50	CD	0
mM	mM	JJ	B-NP
tri	tri	NN	I-NP
(	(	-LRB-	I-NP
hydroxymethyl	hydroxymethyl	LS	I-NP
)	)	-RRB-	I-NP
aminomethane	aminomethane	NN	I-NP
pH	pH	NN	I-NP
8.0	8.0	FW	0
,	,	,	0
15	15	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
and	and	CC	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
.	.	.	0
For	For	IN	0
in	in	IN	0
situ	situ	JJ	B-NP
hybridization	hybridization	NN	I-NP
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
fixed	fixed	VBN	B-NP
in	in	IN	0
4	4	CD	0
%	%	NN	0
paraformaldehyde	paraformaldehyde	VBZ	0
containing	containing	VBG	0
5	5	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
,	,	,	0
incubated	incubated	VBG	0
in	in	IN	0
0.1	0.1	CD	0
M	M	NNP	0
glycine	glycine	NN	B-NP
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
,	,	,	0
dehydrated	dehydrated	CD	0
3	3	CD	0
min	min	CD	B-NP
each	each	DT	0
in	in	IN	0
30	30	CD	0
,	,	,	0
70	70	CD	0
,	,	,	0
and	and	CC	0
100	100	CD	0
%	%	NN	0
ethanol	ethanol	NN	B-NP
,	,	,	0
and	and	CC	0
allowed	allowed	VBN	0
to	to	TO	0
dry	dry	VB	0
.	.	.	0
Prehybridization	Prehybridization	NNP	B-NP
was	was	VBD	0
performed	performed	VBN	0
in	in	IN	0
a	a	DT	0
solution	solution	NN	B-NP
containing	containing	VBG	0
60	60	CD	0
%	%	NN	0
formamide	formamide	NN	B-NP
,	,	,	0
0.1	0.1	CD	0
M	M	NNP	0
piperazine-	piperazine-	NNP	B-NP
N	N	NNP	I-NP
,	,	,	0
N	N	NNP	0
'	'	POS	0
-bis	-bis	JJ	0
(	(	-LRB-	0
2-ethanesulfonic	2-ethanesulfonic	NNP	0
acid	acid	NN	0
)	)	-RRB-	0
pH	pH	JJ	0
6.4	6.4	CD	0
,	,	,	0
0.4	0.4	CD	0
M	M	NNP	0
NaCl	NaCl	NNP	B-NP
,	,	,	0
and	and	CC	0
0.2	0.2	CD	0
e.	e.	NN	B-NP
coli	coli	NN	I-NP
trna	trna	NN	I-NP
mg/ml	mg/ml	NN	I-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
,	,	,	0
St.	St.	NNP	B-NP
Louis	Louis	NNP	0
,	,	,	0
MO	MO	NNP	0
)	)	-RRB-	0
for	for	IN	0
2	2	CD	0
h	h	NN	0
at	at	IN	0
55°C	55°C	CD	0
with	with	IN	0
gentle	gentle	JJ	0
shaking	shaking	NN	0
.	.	.	0
The	The	DT	0
hybridization	hybridization	JJ	B-NP
solution	solution	NN	I-NP
was	was	VBD	0
the	the	DT	0
same	same	JJ	0
as	as	IN	0
the	the	DT	0
prehybridization	prehybridization	JJ	B-NP
solution	solution	NN	I-NP
but	but	CC	0
contained	contained	VBD	0
10	10	CD	0
6cpm	6cpm	CD	0
/	/	CD	0
ml	ml	NN	0
of	of	IN	0
the	the	DT	0
cCAF	cCAF	JJ	B-NP
probe	probe	NN	I-NP
or	or	CC	0
with	with	IN	0
the	the	DT	0
same	same	JJ	0
number	number	NN	0
of	of	IN	0
counts	counts	NNS	0
of	of	IN	0
the	the	DT	0
vector	vector	JJ	B-NP
probe	probe	NN	I-NP
and	and	CC	0
incubated	incubated	NN	0
at	at	IN	0
55°C	55°C	CD	0
for	for	IN	0
48	48	CD	0
h	h	NN	0
with	with	IN	0
gentle	gentle	JJ	0
shaking	shaking	NN	0
.	.	.	0
At	At	IN	0
the	the	DT	0
end	end	NN	0
of	of	IN	0
this	this	DT	0
period	period	NN	0
,	,	,	0
the	the	DT	0
cultures	cultures	NNS	0
were	were	VBD	0
washed	washed	VBN	0
twice	twice	RB	0
with	with	IN	0
2×	2×	NNP	0
SSC	SSC	NNP	B-NP
+	+	CD	0
0.1	0.1	CD	0
%	%	NN	0
Triton-X	Triton-X	JJ	B-NP
100	100	CD	0
for	for	IN	0
1	1	CD	0
h	h	NNS	0
followed	followed	VBN	0
by	by	IN	0
two	two	CD	0
more	more	JJR	0
washes	washes	NN	0
with	with	IN	0
0.1×	0.1×	NNP	0
SSC	SSC	NNP	B-NP
+	+	CD	0
0.1	0.1	CD	0
%	%	NN	0
Triton-X	Triton-X	JJ	B-NP
100	100	CD	0
,	,	,	0
all	all	DT	0
at	at	IN	0
55°C	55°C	CD	0
in	in	IN	0
the	the	DT	0
shaker	shaker	NN	0
.	.	.	0
The	The	DT	0
cultures	cultures	NNS	0
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
dry	dry	VB	0
,	,	,	0
then	then	RB	0
covered	covered	VBN	0
with	with	IN	0
emulsion	emulsion	NN	0
and	and	CC	0
processed	processed	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
Author	Author	NN	0
's	's	POS	0
contribution	contribution	NN	B-NP
JEF	JEF	VBP	0
carried	carried	VBN	0
out	out	RP	0
all	all	DT	0
studies	studies	NNS	0
except	except	IN	0
for	for	IN	0
the	the	DT	0
tenascin	tenascin	NN	B-NP
antisense	antisense	VBD	0
inhibition	inhibition	JJ	B-NP
experiment	experiment	NN	I-NP
.	.	.	0
LW	LW	NNP	B-NP
and	and	CC	0
QJL	QJL	NNP	B-NP
initials	initials	VBD	0
carried	carried	VBN	0
out	out	RP	0
the	the	DT	0
tn	tn	NN	B-NP
antisense	antisense	NN	I-NP
study	study	NN	I-NP
.	.	.	0
MMG	MMG	NNP	B-NP
initials	initials	VBD	0
conceived	conceived	VBN	0
and	and	CC	0
designed	designed	VBN	0
,	,	,	0
with	with	IN	0
JEF	JEF	NNP	B-NP
,	,	,	0
the	the	DT	0
studies	studies	NNS	0
,	,	,	0
and	and	CC	0
contributed	contributed	VBD	0
to	to	TO	0
manuscript	manuscript	VB	B-NP
preparation	preparation	NN	I-NP
and	and	CC	0
submission	submission	NN	0
.	.	.	0
All	All	DT	0
authors	authors	NNS	0
read	read	VBP	0
and	and	CC	0
approved	approved	VBD	0
the	the	DT	0
final	final	JJ	B-NP
manuscript	manuscript	NN	I-NP
.	.	.	0
List	List	NN	0
of	of	IN	0
abbreviation	abbreviation	NN	B-NP
used	used	VBN	0
cCAF	cCAF	JJ	B-NP
chicken	chicken	NN	I-NP
Chemotactic	Chemotactic	NNP	I-NP
and	and	CC	0
chicken	chicken	NN	B-NP
embryo	embryo	NN	I-NP
fibroblast	fibroblast	NN	I-NP
angiogenic	angiogenic	NN	I-NP
factor	factor	NN	I-NP
cef	cef	NN	I-NP
Coll	Coll	NNP	B-NP
collagen	collagen	NN	I-NP
ECM	ECM	NN	I-NP
extracellular	extracellular	NN	I-NP
matrix	matrix	NN	I-NP
FN	FN	NN	I-NP
fibronectin	fibronectin	NN	I-NP
IL-8	IL-8	NN	I-NP
interleukin-8	interleukin-8	NN	I-NP
MCP-1	MCP-1	NN	I-NP
monocyte	monocyte	NN	I-NP
chemotactic	chemotactic	NN	I-NP
protein-1	protein-1	NN	I-NP
MGSA	MGSA	NN	I-NP
melanoma	melanoma	NN	I-NP
growth	growth	NN	I-NP
stimulatory	stimulatory	NN	I-NP
activity	activity	NN	I-NP
MMP	MMP	NN	I-NP
matrix	matrix	NN	I-NP
metalloprotease	metalloprotease	NN	I-NP
PA	PA	NN	I-NP
plasminogen	plasminogen	NN	I-NP
activator	activator	NN	I-NP
TGFβ1	TGFβ1	NN	I-NP
transforming	transforming	FW	0
growth	growth	FW	0
factor	factor	FW	0
β1	β1	FW	0
TIMP	TIMP	FW	0
tissue	tissue	FW	0
inhibitor	inhibitor	FW	0
of	of	FW	0
metalloprotease	metalloprotease	NN	B-NP
TN	TN	NN	I-NP
tenascin	tenascin	NN	I-NP
